<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="iso-abbrev">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title-group><journal-title>Mediators of Inflammation</journal-title></journal-title-group><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5925018</article-id><article-id pub-id-type="doi">10.1155/2018/2503950</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Wound Healing and Omega-6 Fatty Acids: From Inflammation to Repair</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Silva</surname><given-names>J&#x000e9;ssica R.</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Burger</surname><given-names>Beatriz</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>K&#x000fc;hl</surname><given-names>Carolina M. C.</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Candreva</surname><given-names>Thamiris</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>dos Anjos</surname><given-names>Mariah B. P.</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6122-0379</contrib-id><name><surname>Rodrigues</surname><given-names>Hosana G.</given-names></name><email>hosana.rodrigues@fca.unicamp.br</email><xref ref-type="aff" rid="I1"/></contrib></contrib-group><aff id="I1">Laboratory of Nutrients and Tissue Repair, School of Applied Sciences, University of Campinas, Limeira, SP, Brazil</aff><author-notes><fn fn-type="other"><p>Academic Editor: Na&#x000ef;ma Mousta&#x000ef;d-Moussa</p></fn></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>12</day><month>4</month><year>2018</year></pub-date><volume>2018</volume><elocation-id>2503950</elocation-id><history><date date-type="received"><day>4</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>8</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 J&#x000e9;ssica R. Silva et al.</copyright-statement><copyright-year>2018</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Wound healing is an evolutionarily conserved process that is essential for species survival. Wound healing involves a series of biochemical and cellular events that are tightly controlled, divided into 3 concomitant and overlapping phases: inflammation, proliferation, and remodelling. Poor wound healing or a chronic wound represents a silent epidemic that affects billions of people worldwide. Considering the involvement of immune cells in its resolution, recent studies are focused on investigating the roles of immune nutrients such as amino acids, minerals, and fatty acids on wound healing. Among the fatty acids, much attention has been given to omega-6 (<italic>&#x003c9;</italic>-6) fatty acids since they can modulate cell migration and proliferation, phagocytic capacity, and production of inflammatory mediators. The present review summarizes current knowledge about the role of <italic>&#x003c9;</italic>-6 fatty acids in the wound healing context.</p></abstract><funding-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</funding-source><award-id>FAPESP 2013/06810-4</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Wound Healing: A Vital Process</title><p>Wound healing occurs after a chemical, physical, or biological insult results in epithelial barrier disruption. This process involves activation of platelets, neutrophils, macrophages, endothelial cells, keratinocytes, and fibroblasts; moreover, the production and release of protein mediators (growth factors and cytokines) released by these cell types and lipid mediators (prostaglandins, leukotrienes, thromboxanes, and lipoxins) are needed to coordinate the tissue repair and to reestablish tissue homeostasis [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>].</p><p>The process is divided into 3 concomitant and overlapping phases: inflammation, proliferation, and remodelling (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>After a tissue lesion, the disruption in vasculature blocks the oxygen and nutrient supply to the injured area, leading to a hypoxic condition that induces the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) [<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>], initiating a coagulation cascade. Blood elements such as platelets, erythrocytes, and fibrin form a framework for the recruitment of immune cells [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. Platelets produce platelet-derived growth factor (PDGF), transforming growth factor-<italic>&#x003b2;</italic> (TGF-<italic>&#x003b2;</italic>), and epidermal growth factor (EGF) that induce migration and activation of immune cells [<xref rid="B8" ref-type="bibr">8</xref>].</p><p>The extracellular matrix (ECM), which is composed of fibronectin, fibrinogen, fibrin, thrombospondin, and vitronectin, fills the tissue defect and enables migration of different cell types required for the healing process [<xref rid="B9" ref-type="bibr">9</xref>].</p><p>Inflammation is the body's natural and essential defence mechanism responsible for combating antigens, restoring homeostasis, and repairing tissue damage [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. The inflammatory response consists of a variety of events triggered by immune cells, which involves influx of leukocytes to the injured area and production of pro- and anti-inflammatory mediators [<xref rid="B12" ref-type="bibr">12</xref>].</p><p>Neutrophils are the predominant cells in the first hours after the tissue injury, and they respond to proinflammatory cytokines, such as interleukin-1<italic>&#x003b2;</italic> (IL-1<italic>&#x003b2;</italic>), tumor necrosis factor alpha (TNF-<italic>&#x003b1;</italic>), and interferon gamma (IFN-<italic>&#x003b3;</italic>) at the lesion site, phagocytizing microorganisms and cellular debris [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. For microorganism destruction, the degranulation process occurs, releasing granule enzymes such as defensins, cathelicidins, elastase, myeloperoxidase (MPO), lactoferrins, and cathepsins inside the phagosome. In addition to their microbicidal activities, these molecules also act in the chemoattraction of macrophages to the lesion site. They also amplify the production of cytokines and chemokines, such as chemokine C-X-C motif ligand-2 (CXCL2) that will attract macrophages to the wound area. Neutrophils produce IL-1<italic>&#x003b2;</italic>, TNF-<italic>&#x003b1;</italic>, and vascular endothelial growth factor (VEGF) and express PDGF and TGF-<italic>&#x003b2;</italic> receptors [<xref rid="B8" ref-type="bibr">8</xref>]. These cytokines also induce the expression of adhesion molecules on the endothelial cell surface that will interact with selectins and integrins expressed in macrophages, facilitating the rolling, attachment, and transmigration of these cells to injured areas [<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>].</p><p>Macrophages are phagocytes that have PDGF, TGF-<italic>&#x003b2;</italic>, and VEGF receptors, and thus, they migrate in response to mediators produced by platelets and neutrophils in the injured tissue [<xref rid="B8" ref-type="bibr">8</xref>].</p><p>After 72 hours, macrophages are the predominant cells at the wound site, and they release growth factors (VEGF, PDGF, and EGF) and cytokines (IL-1<italic>&#x003b2;</italic>, IL-6, and TNF-<italic>&#x003b1;</italic>) that promote the migration of other cells such as fibroblasts and endothelial cells [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. They also produce prostaglandins that activate endothelial cells and act as potent vasodilators, affecting the permeability of microblood vessels [<xref rid="B17" ref-type="bibr">17</xref>].</p><p>The lack of control in the amplitude and time to resolve inflammation is one of the factors that most influence the genesis of chronic inflammatory diseases, such as cardiovascular diseases, diabetes, cancer, asthma, dementia, and Alzheimer's disease [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B18" ref-type="bibr">18</xref>], as well as chronic wounds.</p><p>The proliferative stage begins within the first 48&#x02009;hours and can unfold up to the 14th day after a tissue injury [<xref rid="B17" ref-type="bibr">17</xref>]. This phase is characterized by angiogenesis and fibroplasia, restoring the blood vessels and forming the granulation tissue [<xref rid="B10" ref-type="bibr">10</xref>].</p><p>Angiogenesis is the formation of new blood vessels from preexisting vessels and it is initiated by growth factors such as VEGF, PDGF, and fibroblast growth factor (FGF) [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B19" ref-type="bibr">19</xref>]. Fibroplasia is the formation of granulation tissue, and its main characteristic is proliferation of fibroblasts in response to PDGF, TGF-<italic>&#x003b2;</italic>, FGF, IL-1, and TNF<italic>&#x003b1;</italic>. At this time, the production of collagen occurs, and there is a release of growth factors such as keratinocyte growth factor (KGF), TNF-<italic>&#x003b1;</italic>, FGF, insulin growth factor (IGF), VEGF, and EGF [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. Then, the provisional matrix initially formed is replaced by granulation tissue composed of fibroblasts, granulocytes, macrophages, and blood vessels in complex with collagen bundles that form the basis for cell adhesion and migration, growth, and differentiation [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B19" ref-type="bibr">19</xref>].</p><p>The remodelling phase occurs approximately from the 21st day after injury and can last for years. During this period, there is intense production and digestion of collagen as well as the substitution of collagen III for collagen I. These events are aimed at maintaining the fibres in the same direction as in unwounded tissue to reestablish its functions and mechanical forces [<xref rid="B20" ref-type="bibr">20</xref>].</p><p>Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that degrade ECM components (collagens), and their gene expression is regulated at the transcriptional level by cytokines and growth factors as well as by their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs) [<xref rid="B21" ref-type="bibr">21</xref>].</p><p>In all of the processes cited above, it is important to emphasize that exogenous and endogenous factors can modulate such events and influence the healing process. More specifically, systemic disorders, such as diabetes, immunosuppression, and venous stasis as well as those resulting from external agents, such as the use of corticotherapy and smoking, can hinder the early closure of the wound.</p><p>Chronic wounds are defined as wounds with a full thickness in depth and a slow healing tendency. The time an open wound needs to remain to define chronicity is still not well established, ranging from 4 weeks to more than 3 months [<xref rid="B22" ref-type="bibr">22</xref>]. Including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, they represent a silent epidemic that affects a large fraction of the world population, becoming a public health problem [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>].</p><p>Complications of chronic wounds include infection that can lead to lower extremity amputations and impacts on health and life quality of patients because they cause pain and suffering, loss of function, loss of productivity, depression, distress and anxiety, social isolation, prolonged hospital stays, and chronic morbidity or even death [<xref rid="B25" ref-type="bibr">25</xref>].</p><p>Moreover, the treatment of chronic wounds causes economic expenditures by the individual and the healthcare system, and therefore, they are a matter of political interest [<xref rid="B26" ref-type="bibr">26</xref>]. In the USA, for example, chronic wounds affect 6.5 million patients, with nearly US$ 50 billion spent on treatment of chronic wounds and complications related to them per year [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B25" ref-type="bibr">25</xref>].</p><p>In developed countries, 1 to 2% of the population will experience a chronic wound throughout their lives [<xref rid="B22" ref-type="bibr">22</xref>] due to population ageing and increases in noncommunicable diseases such as obesity, diabetes, and cancer [<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>].</p><p>Animal and human studies have shown that in the elderly population (age over 60 years), there is an increase in the number of cases of poor wound healing and chronic wounds due to delayed T-cell infiltration, decreased chemokine production, and reduced macrophage phagocytic capacity, in addition to delayed reepithelization, collagen synthesis, and angiogenesis [<xref rid="B28" ref-type="bibr">28</xref>].</p><p>Alterations of the peripheral nervous system with decreased protective sensation and foot deformities enhance the risk of chronic skin ulcerations on the lower extremities of diabetic subjects, mainly on the foot, that affect 15% of diabetic patients [<xref rid="B29" ref-type="bibr">29</xref>], and five-year postamputation, the mortality rate is 50&#x02013;59% [<xref rid="B30" ref-type="bibr">30</xref>].</p><p>Chronic inflammation, insufficient angiogenic response, production of ROS greater than antioxidant capacity, collagen accumulation, dysfunction of migration and proliferation of fibroblast and keratinocytes, and an imbalance between the accumulation and degradation of ECM are some of the mechanisms responsible for poor healing in diabetic patients [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B28" ref-type="bibr">28</xref>].</p><p>These scenarios show the necessity for studies that investigate possible therapies that accelerate tissue repair, reducing the susceptibility to infections [<xref rid="B31" ref-type="bibr">31</xref>].</p></sec><sec id="sec2"><title>2. Omega-6 Fatty Acids: From Inflammation to Regeneration</title><p>For decades, nutritional supplementation was mainly used to avoid nutritional deficiency. However, currently it is being recognized that adequate levels of essential nutrients can prevent as well as treat some disturbances [<xref rid="B32" ref-type="bibr">32</xref>].</p><p>Fatty acids are carboxylic acids formed by hydrogen and carbon atoms [<xref rid="B33" ref-type="bibr">33</xref>]. Based on the presence of double bonds, fatty acids are classified as saturated (no double bonds) or unsaturated (with double bonds). Among the unsaturated fatty acids, there is also a classification that takes into account the number of unsaturations: monounsaturated fatty acids (MUFAs) present with one double bond on acyls (the main food source is olive oil) and polyunsaturated fatty acids (PUFAs) contain two or more double bonds [<xref rid="B33" ref-type="bibr">33</xref>].</p><p>PUFAs are classified by the position of the first double bound counting from the methyl terminal. Then, when the first double bond is at the 6th carbon atom from the methyl terminal, PUFAs are called omega-6, <italic>&#x003c9;</italic>-6, or n-6. They include linoleic acid (LA, C18&#x02009;:&#x02009;2 <italic>&#x003c9;</italic>-6), an essential fatty acid because it cannot be synthesized by the human body. LA can be &#x0201c;stretched&#x0201d; and desaturated into other <italic>&#x003c9;</italic>-6 fatty acids, such as <italic>&#x003b3;</italic>-linolenic (GLA, 18&#x02009;:&#x02009;3 <italic>&#x003c9;</italic>-6) and the arachidonic acid (AA, 20&#x02009;:&#x02009;4 <italic>&#x003c9;</italic>-6). Moreover, biohydration of linoleic acid by bacteria (anaerobic bacteria such as <italic>Butyrivibrio fibrisolvens</italic>) in the gut of animals and the action of &#x00394;9 desaturation of 18&#x02009;:&#x02009;1 <italic>trans</italic>-11 in animal tissue can generate conjugated linoleic acid (CLA) [<xref rid="B34" ref-type="bibr">34</xref>].</p><p>Fatty acids alter skin structural and immunological status since they constitute the stratum corneum, and they can alter the permeability of the skin. They also interfere with maturation and differentiation of the stratum corneum and inhibit production of proinflammatory eicosanoids, reactive species (ROS and RNS), and cytokines, thus influencing the inflammatory response and possibly wound healing [<xref rid="B35" ref-type="bibr">35</xref>&#x02013;<xref rid="B38" ref-type="bibr">38</xref>].</p><p>The objective of this study was to review the scientific literature on the relationship between omega-6 fatty acids (linoleic, conjugated linolenic, gamma-linolenic, and arachidonic acid) and the wound healing process.</p><sec id="sec2.1"><title>2.1. Linoleic Acid</title><p>Linoleic acid (LA, 18&#x02009;:&#x02009;2 <italic>&#x003c9;</italic>-6, <italic>cis</italic>-9, 12-octadecadienoic acid) is the PUFA most commonly consumed in the human diet, being mainly found in safflower, corn, and sunflower oils, present in medium quantities in soy, sesame, and almond oils, and in smaller quantities in canola, olive, coconut, and palm oils [<xref rid="B39" ref-type="bibr">39</xref>].</p><sec id="sec2.1.1"><title>2.1.1. Effects of LA on Tissue Repair</title><p>In developing countries, creams with linoleic acid are used to treat wounds. One of the first studies in this area described that topical application of a solution containing 1.6&#x02009;g of essential fatty acid (mainly linoleic acid) prevented pressure ulcers in hospitalized patients [<xref rid="B40" ref-type="bibr">40</xref>]. This improvement was related to better hydration and elasticity. In this study, the control group received a solution with 1.6&#x02009;g of mineral oil, which is a liquid paraffin. Although frequently used in baby creams to maintain hydration, in the present study, only 22% of the patients in the control group presented a hydrated skin. On the other hand, 98% of the patients treated with a linoleic solution showed a hydrated skin. These results indicate that maintenance of hydration is a mechanism by which linoleic acid improves wound healing.</p><p>In 2008, Magalh&#x000e3;es et al. [<xref rid="B41" ref-type="bibr">41</xref>] did not observe any effects of topical application of medium chain triglycerides (caprylic, capric, caproic, and lauric acids), linoleic acid, soy lecithin, or a vitamin A and E mixture on wound healing in rats. The main problem with this protocol is the composition of the mixture tested and the control used, since the control group received a 0.9% NaCl solution without antioxidant vitamins or fatty acids.</p><p>Other studies described positive effects of oils rich in linoleic acid such as lucuma nut oil (LNO) and pumpkin oil on wound healing [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>]. The major constituents of LNO are LA (38.9%), oleic acid (27.9%), and palmitic and stearic acids (18.6 and 8.9%, resp.). Rojo et al. [<xref rid="B42" ref-type="bibr">42</xref>] used two different models to prove the beneficial effects of LNO: the zebrafish (<italic>Danio rerio</italic>) model and a CD-1 murine model. At first, LNO (20&#x02013;100&#x02009;<italic>&#x003bc;</italic>g/mL) was added to a zebrafish larva plate after a tail primordial cut. Through fluorescence microscopy and image analysis of fluorescent endothelial cells from zebrafish, it was observed that LNO accelerated the regeneration. This prohealing effect was attributed to increases in angiogenesis. However, the authors evaluated the number of fluorescent endothelial cells and not the number of new vessels formed. Angiogenesis is a complex process that involves release of proangiogenic factors, such as VEGF, PDGF, and FGF, as well as proteolytic degradation of basement membrane, and the migration, proliferation, and organization of endothelial cells in a tube form [<xref rid="B44" ref-type="bibr">44</xref>]. Angiogenesis is a crucial step for proper wound healing since it reestablishes the oxygen and nutrient supply.</p><p>LNO was also tested in a CD-1 murine model. For this, a wound was induced in the back region of mice and topically treated with 200, 500, or 100&#x02009;<italic>&#x003bc;</italic>g of LNO daily. Corroborating the results with zebrafish, LNO (500 and 1000&#x02009;<italic>&#x003bc;</italic>g) also induced a more rapid wound closure in CD-1 mice. The authors hypothesize that this effect could be related to the anti-inflammatory actions of the fatty acids present in the LNO [<xref rid="B42" ref-type="bibr">42</xref>]; however, they did not show any results that could support this hypothesis.</p><p>Linoleic acid has been thought to be behind the effects of pumpkin oil on wound healing. Pumpkin oil is constituted, mainly by LA (50%), oleic acid (25%), and palmitic acid (15%) [<xref rid="B43" ref-type="bibr">43</xref>]. This high content of LA was correlated with improvement in wound closure, since it shortened bleeding time, suggesting a stabilization of fibrin and consequent migration of fibroblast; it augmented hydroxyproline content, possibly due to fibroblast activation; and it reduced the number of infiltrating macrophages in wound tissue 11&#x02009;days after lesion induction. Altogether, these results indicate that topical treatment with pumpkin oil accelerates tissue repair, mainly due to the effects of LA [<xref rid="B43" ref-type="bibr">43</xref>].</p><p>Considering these results with LA-rich oils, some groups have tested the effects of pure LA on wound healing. The use of isolated fatty acids ensures that the observed effects are not due to minor oil compounds or a combination of fatty acids.</p><p>In this context, it was also reported that there were beneficial effects of pure LA topically applied into wounds. BALB/c mice treated with pure LA (30&#x000a0;<italic>&#x003bc;</italic>M) for 20&#x02009;days exhibited accelerated tissue repair 48&#x02009;hours after wound induction [<xref rid="B45" ref-type="bibr">45</xref>]. This result was related to increased production of nitric oxide (NO). NO is a free radical derived from L-arginine oxidation through the nitric oxide synthase (NOS) activity. After an inflammatory insult, inducible nitric oxide synthase (iNOS) is expressed in immune cells and produces a large amount of NO that will generate other free radicals, expanding the inflammatory response [<xref rid="B46" ref-type="bibr">46</xref>]. NO plays important roles such as activation of macrophages and fibroblasts, induction of collagen synthesis, and the proliferation of keratinocytes during wound healing, thus accelerating reepithelization [<xref rid="B47" ref-type="bibr">47</xref>].</p><p>However, in Wistar rats, topical treatment with pure LA did not alter the wound area, although there was an increase in wet wound weight (oedema) and in neutrophil numbers, indicating a positive effect on the migratory response during the inflammatory phase [<xref rid="B48" ref-type="bibr">48</xref>].</p><p>Another approach used to investigate LA effects on wound healing is oral supplementation.</p><p>Wistar rats orally supplemented with pure LA (0.22&#x02009;g per kg body weight) by gavage during the 5&#x02009;days prior to wound induction had an increased inflammatory response 1 hour (initial stage of inflammation) after skin injury. This proinflammatory effect was characterized by an increase in inflammatory cell influx into the wound site due to elevations in hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) production and chemokine release. On the other hand, 24&#x02009;hours later, LA reduced the activation of nuclear transcription factor (NF-<italic>&#x003ba;</italic>B) and then diminished the production of proinflammatory cytokines such as IL-1<italic>&#x003b2;</italic> and IL-6. At the same time, there was an elevation in AP-1 (activator protein-1) activation. AP-1 is a transcription factor that induces the expression of genes related to proliferation of keratinocytes and fibroblasts, which are two important cells involved in the proliferative phase of wound healing. Therefore, LA accelerated the inflammatory phase of wound healing, allowing the next phase (proliferation) to start early and accelerating wound healing over a period of 7 days [<xref rid="B49" ref-type="bibr">49</xref>].</p><p>More recently, the same protocol was tested in diabetic Wistar rats; the results showed that LA positively modulates tissue repair not only by accelerating the inflammatory phase but also by inducing angiogenesis. During the proliferative phase (7&#x02009;days), it was observed that LA increased the number of vessels in the wound tissue, which was related to an elevation in VEGF concentration and ANGPT-2 (angiopoietin-2) expression [<xref rid="B38" ref-type="bibr">38</xref>]. VEGF and ANGPT-2 are proangiogenic factors essential for new vessel formation. VEGF induces ANGPT-2 expression, which primes endothelial cells to respond to inflammatory cytokines, thereby augmenting the migration and proliferation of endothelial cells [<xref rid="B50" ref-type="bibr">50</xref>].</p><p>Taken together, these studies demonstrate that linoleic acid can improve wound healing due to its mechanical properties and by modulating the cellular response, increasing the migration and functions of inflammatory and endothelial cells as well as inducing angiogenesis at the wound site.</p></sec><sec id="sec2.1.2"><title>2.1.2. Mechanisms of Action of LA</title><p>The mechanisms described so far to explain the effects of LA on wound healing involve inflammatory responses of neutrophils and macrophages.</p><p>Neutrophils are the first cell type recruited to the inflammatory site, being determinants for the healing process [<xref rid="B51" ref-type="bibr">51</xref>]. To analyse the effects of LA on neutrophil migration, an air pouch was induced into the dorsal region of Wistar rats treated with LA (100&#x02009;<italic>&#x003bc;</italic>M), and 4 hours later, the exudate was collected and the cells were counted. LA increased neutrophil influx to the pouches [<xref rid="B48" ref-type="bibr">48</xref>], corroborating the results described in wound tissue. This effect on migration can be explained by the induction of adhesion molecules such as L-selectin on neutrophil surfaces [<xref rid="B52" ref-type="bibr">52</xref>]. Neutrophil recruitment is a highly regulated process that involves at least four steps: rolling, activation, adhesion, and transmigration. Through the intravital microscopy assay, it was observed that LA also elevated leukocyte-endothelium interactions (rolling and adhesion) [<xref rid="B52" ref-type="bibr">52</xref>].</p><p>Once in the injured site, neutrophils produce cytokines, chemokines, ROS, and other molecules to expand the inflammatory response. Measuring intra or extracellular ROS production, Hatanaka et al. [<xref rid="B53" ref-type="bibr">53</xref>] demonstrated that LA increased anion superoxide and H<sub>2</sub>O<sub>2</sub> in a dose-dependent manner. The authors tested 5 different techniques (luminol- and lucigenin-amplified chemiluminescence, cytochrome c, hydroethidine, and phenol red reduction) and described that LA interfered with luminol and cytochrome c reactions, jeopardizing the ROS results [<xref rid="B53" ref-type="bibr">53</xref>]. In the wound healing context, ROS production is the first event that occurs after tissue disruption due to hypoxia [<xref rid="B54" ref-type="bibr">54</xref>]. Low concentrations of H<sub>2</sub>O<sub>2</sub> are important to support wound healing [<xref rid="B55" ref-type="bibr">55</xref>] since ROS not only disinfects the injured area but also acts as signalling messengers regulating gene expression [<xref rid="B56" ref-type="bibr">56</xref>] and cellular function such as migration [<xref rid="B57" ref-type="bibr">57</xref>] and cytokine production [<xref rid="B58" ref-type="bibr">58</xref>].</p><p>Inflammation control is crucial to tissue repair, since chronic inflammation can worsen the wound. In this sense, LA has also shown a beneficial effect since it increases the release of proinflammatory mediators in the initial inflammation phase (1&#x02013;4&#x02009;hours) and reduces them in the resolution phase (18&#x02013;48&#x02009;hours) [<xref rid="B52" ref-type="bibr">52</xref>].</p><p>Another important cell type that is involved in inflammatory responses is the macrophage. As observed with neutrophils, LA reduced the production of IL-1<italic>&#x003b2;</italic>, IL-6, and VEGF in the absence of LPS, although it accelerated IL-1<italic>&#x003b2;</italic> release and decreased IL-10 synthesis when cells were stimulated with LPS. However, LA did not affect ROS production (superoxide anion, hydrogen peroxide, and NO) as well as the lipid mediators, prostaglandin E<sub>2</sub> (PGE2), leukotriene B<sub>4</sub> (LTB<sub>4</sub>), and 15(S)-hydroxyeicosatetraenoic acid (15[2]-HETE) [<xref rid="B59" ref-type="bibr">59</xref>]. Lipid mediators are a class of inflammatory molecules derived from the metabolization of arachidonic [<xref rid="B60" ref-type="bibr">60</xref>], eicosapentaenoic (EPA), or docosahexaenoic (DHA) acids. Classes 2 and 4 are derived from AA and exhibit more proinflammatory effects, increasing migration, production of cytokines, and ROS. On the other hand, classes 3 and 5 are derived from EPA and DHA and are related to anti-inflammatory effects. More recently, a new class of lipid mediators derived from omega-3 fatty acids (EPA and DHA) were described, the maresins, resolvins, and protectins that exert proresolution effects, resolving inflammation [<xref rid="B61" ref-type="bibr">61</xref>]. During the inflammatory response, it is important that there is a shift between proinflammatory molecules to proresolution to limit the damage induced by exacerbated inflammation.</p><p>During the proliferation and remodelling phases, fibroblasts, endothelial cells, and keratinocytes play important roles in producing growth factors that orchestrate the reconstruction of vessels and induce wound contraction [<xref rid="B62" ref-type="bibr">62</xref>]. In this context, Rojo et al. [<xref rid="B42" ref-type="bibr">42</xref>] described a promigratory effect of LNO (60&#x02009;<italic>&#x003bc;</italic>g/mL) on human fibroblasts, which was related to an increase in vinculin expression. Vinculin is a focal adhesion protein essential for fibroblasts-ECM interactions [<xref rid="B63" ref-type="bibr">63</xref>] involved in wound contraction.</p><p>One important aspect not fully clarified is if LA must be metabolized to exert its effects on cellular functions or if it acts as an effector molecule. To answer this question, some studies have described G-protein coupled receptors (GPCR or GPR) as responsible for fatty acid effects [<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>]. GPR is a class of seven transmembrane receptors involved in a broad spectrum of cellular responses [<xref rid="B64" ref-type="bibr">64</xref>]. Among GPR, GPR40 has been described as a sensor for LA, oleic acid (OA), CLA, and other long chain fatty acids [<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>]. In HaCaT cells (keratinocyte cell line), once activated, it reduced the production of cytokines (CCL-5 and CCL17) and suppressed allergic inflammation in skin [<xref rid="B67" ref-type="bibr">67</xref>], and then, it could be involved in the effects of LA on wound healing. These results indicate that LA can modulate immune response by acting as an effector molecule. However, considering the importance of LA to cellular membranes, it is possible that the results observed are due to its metabolization as well. More studies are needed to clarify this point.</p><p>In conclusion, it has been shown that LA-rich oil or pure LA modulates cellular functions such as migration, production of ROS, cytokines, and chemokines, expression of adhesion molecules, and interaction with ECM. These alterations seem to be related to improvements in tissue repair.</p></sec></sec><sec id="sec2.2"><title>2.2. Conjugated Linoleic Acid (CLA)</title><p>The presence of conjugated linoleic acid (CLA) was first reported in 1930 [<xref rid="B68" ref-type="bibr">68</xref>], but only in the 1980s was CLA described as a bioactive dietary constituent, and the interest in CLA's effects has increased due its anticarcinogenic properties and reduction of adipose tissue mass observed in mice [<xref rid="B69" ref-type="bibr">69</xref>].</p><p>CLA comprises a mix of positional and geometric isomers of linoleic acid with a single pair of conjugated double bonds. CLA is formed during LA biohydration by bacteria in the gut of ruminant animals, and thus, the main natural sources of CLA are ruminant meats (beef and lamb) and dairy products (milk and cheese) [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>].</p><p>At least 28 CLA isomers are known, but the <italic>cis</italic>-9, <italic>trans</italic>-11 (c9, t11) is the most abundant form of CLA in nature, and nutritional supplements are a mixture of c9, t11 and <italic>trans</italic>-10, <italic>cis</italic>-12 (t10, c12) CLA [<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>]. Initially, it was thought that the effects of CLA were global, and the results were due to interactions between its two main isomers: c9, t11 and t10, c12. However, later evidence suggested that the physiological effects of CLA may be different between the isomers, animal species (rats and mice), and cell types [<xref rid="B73" ref-type="bibr">73</xref>].</p><p>The last decade has seen a plethora of claims, supported by animal and cell lineage models, that dietary CLA intake is associated with potential health benefits [<xref rid="B70" ref-type="bibr">70</xref>]. These include reduction in fat deposition, protection from atherosclerosis and cancer, and enhanced immunity [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B74" ref-type="bibr">74</xref>].</p><p>Although preclinical data suggest benefits of CLA supplementation, clinical findings in humans have yet to show evidence of a positive effect, and even the findings in animals are still controversial [<xref rid="B73" ref-type="bibr">73</xref>].</p><p>Some studies revealed that CLA can induce adverse effects such as fatty liver, insulin resistance, and lipodystrophy [<xref rid="B75" ref-type="bibr">75</xref>]. Thus, it is recommended that ingestion of a balanced diet with natural sources of CLA be followed.</p><sec id="sec2.2.1"><title>2.2.1. Effects of CLA on Tissue Repair</title><p>Mice fed a diet supplemented with 0.5% or 1% CLA (38% c9, t11 CLA; 39% t10, c12 CLA; 3% c9, c11 CLA; and 1% t9, t11 CLA) for 2 weeks presented a reduction in wound area (1% CLA) that was related to an increase in antioxidant defences [<xref rid="B76" ref-type="bibr">76</xref>]. ROS are essential to protect the organism against invading bacteria and other microorganisms; moreover, they are important to intracellular signalling. However, excessive production of ROS or impaired detoxification of these molecules causes oxidative stress [<xref rid="B54" ref-type="bibr">54</xref>]. To understand the prohealing effect, the authors measured malondialdehyde (MDA) content in the liver, a marker of lipid peroxidation, and the expression of antioxidant enzymes at the wound site. Mice supplemented with CLA had a reduced MDA content and increased CuZn superoxide dismutase (SOD) and MnSOD protein expression, showing an antioxidant effect of this fatty acid, which can explain its benefit on wound healing. At the same time, they described a reduction of phosphorylated inhibitor kappa B alpha (pI<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic>) protein expression at the end of the inflammatory phase of wound healing [<xref rid="B76" ref-type="bibr">76</xref>]. In the cytoplasm, NF-<italic>&#x003ba;</italic>B is found complexed with I<italic>&#x003ba;</italic>B. Once phosphorylated, I<italic>&#x003ba;</italic>B releases NF-<italic>&#x003ba;</italic>B that translocates to the nucleus and induces the expression of genes related to inflammatory responses [<xref rid="B77" ref-type="bibr">77</xref>]. Therefore, the reduction in pI<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> indicates that NF-<italic>&#x003ba;</italic>B is in the cytoplasm, and the expression of proinflammatory genes is reduced. To show this, the expression of cyclooxygenase-2 (COX-2) and HO-1 was evaluated. CLA reduced the protein expression of these inflammatory genes, confirming its inhibitory effect on NF-<italic>&#x003ba;</italic>B activation [<xref rid="B76" ref-type="bibr">76</xref>].</p><p>In the carcinogenic context, topical application of CLA to hairless mouse skin also reduced COX-2 expression due to inhibition of NF-<italic>&#x003ba;</italic>B activation in the skin [<xref rid="B78" ref-type="bibr">78</xref>]. To elucidate the CLA effects on the NF-<italic>&#x003ba;</italic>B pathway, it was described that this fatty acid downregulated the catalytic activity of I<italic>&#x003ba;</italic>B kinase (IKK<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic>), mitogen-activated protein kinase (p38 MAPK), and protein kinase B (Akt) [<xref rid="B78" ref-type="bibr">78</xref>]. We suggest Zhang et al. [<xref rid="B77" ref-type="bibr">77</xref>] for a comprehensive review of the NF-<italic>&#x003ba;</italic>B signalling pathway.</p></sec><sec id="sec2.2.2"><title>2.2.2. Mechanisms of Action of CLA</title><p>The mechanisms by which CLA modulates immune function are not completely elucidated, but they include regulation of prostaglandin and cytokine production, since it has been observed that CLA reduces COX-2 expression and modulates NF-<italic>&#x003ba;</italic>B activation [<xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B79" ref-type="bibr">79</xref>].</p><p>Peripheral blood mononuclear cells (PBMC) treated with t10, c12 CLA (100&#x02009;<italic>&#x003bc;</italic>M) for 24&#x02009;hours diminished TNF-<italic>&#x003b1;</italic> production. This effect seems to be isomer-specific since treatment with c9, t11 CLA (100&#x02009;<italic>&#x003bc;</italic>M) or LA (100&#x02009;<italic>&#x003bc;</italic>M) had no effect on TNF-<italic>&#x003b1;</italic> concentration [<xref rid="B80" ref-type="bibr">80</xref>].</p><p>Cho et al. [<xref rid="B81" ref-type="bibr">81</xref>] suggested that t10, c12 CLA has a priming effect on polymorphonuclear (PMN) and mononuclear cells isolated from dogs. PMN or mononuclear cells directly treated with CLA did not alter TNF-<italic>&#x003b1;</italic> production. Thus, they took this preconditioned medium and added it to a new cell culture. This preconditioned medium increased TNF-<italic>&#x003b1;</italic> concentrations and augmented the oxidative burst activity and phagocytic capacity of PMN and mononuclear cells [<xref rid="B81" ref-type="bibr">81</xref>]. When the recombinant anti-TNF-<italic>&#x003b1;</italic> antibody was added to this preconditioned medium, the effects were abolished, suggesting that the effects of CLA are mediated by TNF-<italic>&#x003b1;</italic> released from PBMC.</p><p>Taken together, these results showed that dietary administration of CLA can improve wound healing due to antioxidant and anti-inflammatory effects in the later inflammatory phase of tissue repair.</p></sec></sec><sec id="sec2.3"><title>2.3. Gamma Linolenic Acid (GLA)</title><p>Gamma-linolenic acid (GLA, 18&#x02009;:&#x02009;3 <italic>&#x003c9;</italic>-6) is an omega-6 fatty acid formed through LA metabolization, due to delta-6-desaturase action [<xref rid="B82" ref-type="bibr">82</xref>]. It is found in plant seed oils, such as borage, black current seed, and primrose oil [<xref rid="B83" ref-type="bibr">83</xref>]. The most common form of GLA consumption is through oral supplementation with GLA-rich oil capsules, mainly from evening primrose oil (EPO) [<xref rid="B84" ref-type="bibr">84</xref>].</p><p>GLA has been investigated in chronic inflammatory diseases such as rheumatoid arthritis [<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>], atopic dermatitis, acne vulgaris, and psoriasis [<xref rid="B87" ref-type="bibr">87</xref>&#x02013;<xref rid="B89" ref-type="bibr">89</xref>] due to its anti-inflammatory effects. GLA can be converted into dihomo-<italic>&#x003b3;</italic>-linoleic acid (DGLA), which is metabolized into prostaglandin E1 (PGE1) or 15-hydroxyeicosatrienoic acid (15-HETrE) [<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B89" ref-type="bibr">89</xref>]. These eicosanoids have anti-inflammatory and immunoregulatory effects [<xref rid="B85" ref-type="bibr">85</xref>].</p><sec id="sec2.3.1"><title>2.3.1. Effects of GLA on Tissue Repair</title><p>GLA ingestion was also used to treat patients with acne vulgaris [<xref rid="B88" ref-type="bibr">88</xref>]. In this study, 45 patients received 2 capsules of borage oil (400&#x02009;mg of GLA) for 10 weeks, and acne lesion number and severity were assessed as well as inflammation by histological analysis. The GLA group had a reduction in the lesion number and severity, which could be associated with a reduction in inflammation and interleukin-8 (IL-8) staining demonstrated by histologic analysis [<xref rid="B88" ref-type="bibr">88</xref>]. Although the authors speculate that two mechanisms (modulation of inflammation and improvement of skin quality) could explain their results, no other analyses were made of their samples. Therefore, it is not possible to affirm how GLA had beneficial effects on acnes vulgaris.</p><p>Ingestion of GLA-rich oil capsules was also related to clinical improvement of atopic dermatitis (AD) [<xref rid="B89" ref-type="bibr">89</xref>]. The clinical effect was positively correlated with plasma GLA and DGLA concentrations after 4 weeks of capsule consumption.</p></sec><sec id="sec2.3.2"><title>2.3.2. Mechanisms of Action of GLA</title><p>Considering the relevance of macrophages in inflammatory processes such as arthritis and wound healing, it is of great value to investigate the effects of GLA on their functions.</p><p>In the RAW 264.7 macrophage cell line, GLA concentrations (100 to 200&#x02009;<italic>&#x003bc;</italic>M) reduced the expression of inducible nitric oxide synthase (iNOS) and consequently the NO concentration [<xref rid="B90" ref-type="bibr">90</xref>]. GLA also inhibited the expression of COX-2 and prointerleukin-1, suggesting a reduction in inflammatory responses. To explain these results, the authors evaluated the expression of proteins involved in the NF-<italic>&#x003ba;</italic>B pathway. GLA diminished I<italic>&#x003ba;</italic>B phosphorylation and degradation, blocking the transmigration of NF-<italic>&#x003ba;</italic>B to the nucleus, which was confirmed by the reduction in nuclear p65 protein expression. Altogether, these results explain the reduced activation of NF-<italic>&#x003ba;</italic>B in GLA-treated macrophages [<xref rid="B90" ref-type="bibr">90</xref>].</p><p>More studies are necessary to prove the beneficial effects of GLA on wound healing.</p></sec></sec><sec id="sec2.4"><title>2.4. Arachidonic Acid</title><p>Arachidonic acid (AA, 20&#x02009;:&#x02009;4 <italic>&#x003c9;</italic>-6) is the second most abundant fatty acid in injured tissue after a tissue lesion [<xref rid="B91" ref-type="bibr">91</xref>]. Once released from membrane phospholipids by phospholipase A<sub>2</sub>, AA is metabolized by cyclooxygenases and lipoxygenases and produces the eicosanoids [<xref rid="B92" ref-type="bibr">92</xref>].</p><p>Eicosanoids are a wide variety of 20-carbon bioactive lipid products that include prostaglandins (PGs) and thromboxanes (TXs) of series 2 and leukotrienes (LTs) of series 4, lipoxins (LXs), hydroxyeicosatetraenoic acids (HETEs), and epoxyeicosatrienoic acids (EETs) [<xref rid="B93" ref-type="bibr">93</xref>] that modulate inflammatory responses. They are highly potent, short-lived molecules that act locally and have been strongly associated with a variety of physiological and pathological processes including cancer, inflammatory diseases, and wound healing [<xref rid="B92" ref-type="bibr">92</xref>]. In the wound healing process, the effects of AA are associated mainly with the production of eicosanoids, because they are abundant in the wound bed [<xref rid="B94" ref-type="bibr">94</xref>].</p><p>The AA metabolites are predominantly proinflammatory because they stimulate the chemotaxis of inflammatory cells, increase the activity of elastase that degrades extracellular proteins, and impair the formation and remodelling of healing tissue [<xref rid="B94" ref-type="bibr">94</xref>].</p><sec id="sec2.4.1"><title>2.4.1. Effects of AA on Tissue Repair</title><p>Considering that AA generates eicosanoids and that these molecules modulate tissue repair, an AA-enriched diet was tested in an intestinal ischaemia-injured model [<xref rid="B95" ref-type="bibr">95</xref>]. The diets were enriched with 0.5 or 5% of AA and administered over 10&#x02009;days to pigs. After this period, blockage of the mesenteric blood vessels induced an ischaemic ileum injury, and the protective and reparative effects of AA administration were analysed. It was observed there was a protective effect of AA (5%) since the percentage of denuded villus area was reduced in relationship to the control. At the same time, the AA group presented an improvement in recovery since these animals showed a reduction in mucosal-to-serosal flux of <sup>3</sup>H-mannitol and <sup>14</sup>C-inulin when compared with the control group (0% of AA), suggesting that the epithelial barrier is more preserved in the AA group [<xref rid="B95" ref-type="bibr">95</xref>]. Although AA-enriched diet (5%) does not alter COX-2 mRNA expression, it was observed that there was an increase in PGE<sub>2</sub> concentration after ischaemic injury [<xref rid="B95" ref-type="bibr">95</xref>]. This effect was abolished when animals received indomethacin, a nonselective COX inhibitor. PGE<sub>2</sub> has been described to be a protective factor that stimulates the recovery of gut injury [<xref rid="B96" ref-type="bibr">96</xref>]. One of the mechanisms involved is the induction of angiogenesis due to an increase in VEGF content [<xref rid="B97" ref-type="bibr">97</xref>].</p><p>In the dextran sodium sulphate-induced inflammatory bowel disease (IBD) model, oral administration of AA (240&#x02009;mg/kg of body weight) for 8 weeks aggravated inflammation since it increased COX-2, LTB<sub>4</sub>, and TXB<sub>2</sub> concentrations in colonic tissue. AA also elevated myeloperoxidase (MPO) activity and macrophage infiltration, which reinforces its proinflammatory effect [<xref rid="B98" ref-type="bibr">98</xref>].</p><p>Epoxyeicosatrienoic acids (EETs) are metabolites produced from AA due to cytochrome P450 (CYP450) activity, predominantly in the endothelium. EETs can stimulate angiogenesis and organ or tissue regeneration [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B99" ref-type="bibr">99</xref>]. Local application of 11,12- or 14,15-EETs (10&#x02009;<italic>&#x003bc;</italic>M/methylcellulose discs) accelerated wound healing due to the increase in MMP2 and MMP7 and reduction in TIMP-1 and TNF-<italic>&#x003b1;</italic> during the proliferative phase of wound healing (12&#x02009;days). These results indicate that EETs favoured extracellular matrix degradation and endothelial cell migration, two important steps in the angiogenesis process [<xref rid="B21" ref-type="bibr">21</xref>]. These positive effects were also confirmed in transgenic animals that exhibit high or low EET. In this model, the wound healing was accelerated in high EET animals due to vascularization [<xref rid="B100" ref-type="bibr">100</xref>].</p><p>To better explain the roles of lipid mediators during impaired wound healing, a lipidomic approach was carried out in transgenic animals (LIGHT<sup>&#x02212;/&#x02212;</sup>) that exhibited an exacerbated inflammatory response characterized by high levels of oxidative stress and cytokines and imbalance between production and degradation of ECM [<xref rid="B99" ref-type="bibr">99</xref>]. These animals had increased concentrations of 11-, 12-, and 15-hydroxyeicosatetraenoic acid, leukotrienes (LTD<sub>4</sub> and LTE), prostaglandins (PGE<sub>2</sub> and PGF<sub>2</sub>), thromboxane (TXA<sub>2</sub>/TXB<sub>2</sub>), and prostacyclins in early stages (1&#x02009;day) of wound healing. These results were associated with enhanced coagulation and infiltration of neutrophils in LIGHT<sup>&#x02212;/&#x02212;</sup> when compared with wild type mice [<xref rid="B99" ref-type="bibr">99</xref>].</p><p>The factors that lead to colitis, ischemia-reperfusion damage, and skin wound are physiologically different as well as the responses observed in these conditions. Although a general inflammatory response is usually observed, which is characterized by recruitment and activation of inflammatory cells, production of cytokines and growth factors as well as the repair of the damaged tissue, there are specificities inherent to each tissue that can change the effect of determined fatty acid.</p></sec><sec id="sec2.4.2"><title>2.4.2. Mechanisms of Action of AA</title><p>In agreement with the <italic>in vivo</italic> studies, AA induced endothelial cell adhesion <italic>in vitro</italic>. Once again, this modulatory effect presented a biphasic pattern as also observed with other fatty acids, such as LA. In the first phase, the positive effect on cell spreading was independent of AA concentration. However, in the later phase, there was an inverse correlation between AA concentration and spreading [<xref rid="B101" ref-type="bibr">101</xref>]. Low AA concentrations (20&#x02009;<italic>&#x003bc;</italic>M) increased cell spreading, and high AA concentrations (80&#x02009;<italic>&#x003bc;</italic>M) reduced it. This effect could be associated with the metabolites generated from AA oxidation. At a low concentration, AA is totally metabolized, and the products can induce cell adhesion. On the other hand, at high concentrations, the reaction is saturated in AA, and the enzymes involved are not sufficient to metabolize all AA available. Then, there is a reduction in AA metabolites and consequently a reduction in cell spreading [<xref rid="B101" ref-type="bibr">101</xref>]. AA also randomizes the migration of endothelial cells. This action is related to the loss of direction during migration due to the presence of AA and seems to be inversely correlated with AA concentration [<xref rid="B101" ref-type="bibr">101</xref>].</p><p>Some of these AA effects, observed in endothelial cells, were also described in human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs), and once again, AA concentration was inversely related with the migratory response. The mechanism behind this effect seems to involve GPR40 [<xref rid="B91" ref-type="bibr">91</xref>], a membrane receptor for fatty acids [<xref rid="B102" ref-type="bibr">102</xref>].</p><p>In a very detailed study, Oh et al. [<xref rid="B91" ref-type="bibr">91</xref>] demonstrated that AA binds to GPR40 and then induces mammalian target of rapamycin complex 1 (mTORC2) phosphorylation (mTOR<sup>ser2481</sup>) that activates Akt<sup>ser407</sup>, which phosphorylates protein kinase C<italic>&#x003b6;</italic> (PKC<italic>&#x003b6;</italic>). pPKC<italic>&#x003b6;</italic> activates p38, through Sp1 phosphorylation, and increases the expression of matrix metalloproteinases (MMPs). MMP degrades fibronectin, an extracellular matrix component, promoting the migration of hUCB-MSCs.</p><p>Altogether, the studies demonstrate that AA and its metabolites promote wound healing due to induction of cell migration and angiogenesis. However, these positive effects are closely related with the concentrations used.</p></sec></sec></sec><sec id="sec3"><title>3. Summary</title><p>Wound healing is an evolutionarily conserved process essential for species' survival. An investigation of factors that improve wound healing is of crucial interest. Experimental and clinical studies indicate that LA improves wound healing due to its biphasic effects on the inflammatory phase of tissue repair (<xref ref-type="table" rid="tab1">Table 1</xref>). CLA seems to have antioxidant and anti-inflammatory effects on the later inflammatory phase of tissue repair, favouring the beginning of the proliferative phase (<xref ref-type="table" rid="tab2">Table 2</xref>). Although less studied, GLA presented positive effects controlling inflammation (<xref ref-type="table" rid="tab3">Table 3</xref>). Studies investigating the effects of AA demonstrated that AA and its metabolites promoted wound healing due to induction of cell migration and angiogenesis (<xref ref-type="table" rid="tab4">Table 4</xref>).</p><p>In general, omega-6 fatty acids positively modulate all phases of wound healing, but more studies are necessary to clarify the mechanisms involved (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Clinical studies are essential to establish the strategies of fatty acid administration (topically or orally), the optimal concentrations, and their safety.</p></sec></body><back><sec><title>Conflicts of Interest</title><p>None of the authors have any conflict of interest or anything to disclose.</p></sec><sec><title>Authors' Contributions</title><p>All authors did the literature search. J&#x000e9;ssica R. Silva and Beatriz Burger wrote the manuscript and contributed equally to this paper. Hosana G. Rodrigues also wrote the manuscript and critically revised the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This research was supported by the Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (FAPESP 2013/06810-4).</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brem</surname><given-names>H.</given-names></name><name><surname>Tomic-Canic</surname><given-names>M.</given-names></name></person-group><article-title>Cellular and molecular basis of wound healing in diabetes</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2007</year><volume>117</volume><issue>5</issue><fpage>1219</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1172/JCI32169</pub-id><pub-id pub-id-type="other">2-s2.0-34248225758</pub-id><?supplied-pmid 17476353?><pub-id pub-id-type="pmid">17476353</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.-S.</given-names></name><name><surname>Chen</surname><given-names>S.-N.</given-names></name></person-group><article-title>Apoptotic cell: linkage of inflammation and wound healing</article-title><source><italic>Frontiers in Pharmacology</italic></source><year>2014</year><volume>5</volume><fpage>p. 1</fpage><pub-id pub-id-type="doi">10.3389/fphar.2014.00001</pub-id><pub-id pub-id-type="other">2-s2.0-84893435713</pub-id><?supplied-pmid 24478702?><pub-id pub-id-type="pmid">24478702</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loree</surname><given-names>J. M.</given-names></name><name><surname>Pereira</surname><given-names>A. A. L.</given-names></name><name><surname>Lam</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes</article-title><source><italic>Clinical Cancer Research</italic></source><year>2018</year><volume>24</volume><issue>5</issue><fpage>1062</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.ccr-17-2484</pub-id><?supplied-pmid 29180604?><pub-id pub-id-type="pmid">29180604</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunnill</surname><given-names>C.</given-names></name><name><surname>Patton</surname><given-names>T.</given-names></name><name><surname>Brennan</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process</article-title><source><italic>International Wound Journal</italic></source><year>2017</year><volume>14</volume><issue>1</issue><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1111/iwj.12557</pub-id><pub-id pub-id-type="other">2-s2.0-85008392511</pub-id><?supplied-pmid 26688157?><pub-id pub-id-type="pmid">26688157</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nauta</surname><given-names>T.</given-names></name><name><surname>van Hinsbergh</surname><given-names>V.</given-names></name><name><surname>Koolwijk</surname><given-names>P.</given-names></name></person-group><article-title>Hypoxic signaling during tissue repair and regenerative medicine</article-title><source><italic>International Journal of Molecular Sciences</italic></source><year>2014</year><volume>15</volume><issue>11</issue><fpage>19791</fpage><lpage>19815</lpage><pub-id pub-id-type="doi">10.3390/ijms151119791</pub-id><pub-id pub-id-type="other">2-s2.0-84908349650</pub-id><?supplied-pmid 25365172?><pub-id pub-id-type="pmid">25365172</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menter</surname><given-names>D. G.</given-names></name><name><surname>Kopetz</surname><given-names>S.</given-names></name><name><surname>Hawk</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Platelet &#x0201c;first responders&#x0201d; in wound response, cancer, and metastasis</article-title><source><italic>Cancer Metastasis Reviews</italic></source><year>2017</year><volume>36</volume><issue>2</issue><fpage>199</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/s10555-017-9682-0</pub-id><pub-id pub-id-type="other">2-s2.0-85025141832</pub-id><?supplied-pmid 28730545?><pub-id pub-id-type="pmid">28730545</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Jackson</surname><given-names>C. J.</given-names></name></person-group><article-title>Extracellular matrix reorganization during wound healing and its impact on abnormal scarring</article-title><source><italic>Advances in Wound Care</italic></source><year>2015</year><volume>4</volume><issue>3</issue><fpage>119</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1089/wound.2013.0485</pub-id><?supplied-pmid 25785236?><pub-id pub-id-type="pmid">25785236</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eming</surname><given-names>S. A.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>Tomic-Canic</surname><given-names>M.</given-names></name></person-group><article-title>Wound repair and regeneration: mechanisms, signaling, and translation</article-title><source><italic>Science Translational Medicine</italic></source><year>2014</year><volume>6</volume><issue>265, article 265sr6</issue><pub-id pub-id-type="doi">10.1126/scitranslmed.3009337</pub-id><pub-id pub-id-type="other">2-s2.0-84915789422</pub-id><?supplied-pmid 25473038?><pub-id pub-id-type="pmid">25473038</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracy</surname><given-names>L. E.</given-names></name><name><surname>Minasian</surname><given-names>R. A.</given-names></name><name><surname>Caterson</surname><given-names>E. J.</given-names></name></person-group><article-title>Extracellular matrix and dermal fibroblast function in the healing wound</article-title><source><italic>Advances in Wound Care</italic></source><year>2016</year><volume>5</volume><issue>3</issue><fpage>119</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1089/wound.2014.0561</pub-id><?supplied-pmid 26989578?><pub-id pub-id-type="pmid">26989578</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landen</surname><given-names>N. X.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>St&#x000e5;hle</surname><given-names>M.</given-names></name></person-group><article-title>Transition from inflammation to proliferation: a critical step during wound healing</article-title><source><italic>Cellular and Molecular Life Sciences</italic></source><year>2016</year><volume>73</volume><issue>20</issue><fpage>3861</fpage><lpage>3885</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2268-0</pub-id><pub-id pub-id-type="other">2-s2.0-84968653109</pub-id><?supplied-pmid 27180275?><pub-id pub-id-type="pmid">27180275</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raphael</surname><given-names>W.</given-names></name><name><surname>Sordillo</surname><given-names>L.</given-names></name></person-group><article-title>Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis</article-title><source><italic>International Journal of Molecular Sciences</italic></source><year>2013</year><volume>14</volume><issue>10</issue><fpage>21167</fpage><lpage>21188</lpage><pub-id pub-id-type="doi">10.3390/ijms141021167</pub-id><pub-id pub-id-type="other">2-s2.0-84886257922</pub-id><?supplied-pmid 24152446?><pub-id pub-id-type="pmid">24152446</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>P. C.</given-names></name></person-group><article-title>Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?</article-title><source><italic>British Journal of Clinical Pharmacology</italic></source><year>2013</year><volume>75</volume><issue>3</issue><fpage>645</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2012.04374.x</pub-id><pub-id pub-id-type="other">2-s2.0-84873443547</pub-id><?supplied-pmid 22765297?><pub-id pub-id-type="pmid">22765297</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>T. J.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name></person-group><article-title>Wound repair at a glance</article-title><source><italic>Journal of Cell Science</italic></source><year>2009</year><volume>122</volume><issue>18</issue><fpage>3209</fpage><lpage>3213</lpage><pub-id pub-id-type="doi">10.1242/jcs.031187</pub-id><pub-id pub-id-type="other">2-s2.0-70350376721</pub-id><?supplied-pmid 19726630?><pub-id pub-id-type="pmid">19726630</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurtner</surname><given-names>G. C.</given-names></name><name><surname>Werner</surname><given-names>S.</given-names></name><name><surname>Barrandon</surname><given-names>Y.</given-names></name><name><surname>Longaker</surname><given-names>M. T.</given-names></name></person-group><article-title>Wound repair and regeneration</article-title><source><italic>Nature</italic></source><year>2008</year><volume>453</volume><issue>7193</issue><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/nature07039</pub-id><pub-id pub-id-type="other">2-s2.0-43749088730</pub-id><?supplied-pmid 18480812?><pub-id pub-id-type="pmid">18480812</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eming</surname><given-names>S. A.</given-names></name><name><surname>Wynn</surname><given-names>T. A.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name></person-group><article-title>Inflammation and metabolism in tissue repair and regeneration</article-title><source><italic>Science</italic></source><year>2017</year><volume>356</volume><issue>6342</issue><fpage>1026</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1126/science.aam7928</pub-id><pub-id pub-id-type="other">2-s2.0-85020377962</pub-id><?supplied-pmid 28596335?><pub-id pub-id-type="pmid">28596335</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>O.</given-names></name><name><surname>Barbul</surname><given-names>A.</given-names></name></person-group><article-title>Immunonutrition: role in wound healing and tissue regeneration</article-title><source><italic>Advances in Wound Care</italic></source><year>2014</year><volume>3</volume><issue>1</issue><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1089/wound.2012.0415</pub-id><?supplied-pmid 24761344?><pub-id pub-id-type="pmid">24761344</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Kirsner</surname><given-names>R.</given-names></name></person-group><article-title>Pathophysiology of acute wound healing</article-title><source><italic>Clinics in Dermatology</italic></source><year>2007</year><volume>25</volume><issue>1</issue><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2006.09.007</pub-id><pub-id pub-id-type="other">2-s2.0-33846627240</pub-id><?supplied-pmid 17276196?><pub-id pub-id-type="pmid">17276196</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilton</surname><given-names>F.</given-names></name><name><surname>Murphy</surname><given-names>R.</given-names></name><name><surname>Wilson</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases</article-title><source><italic>Nutrients</italic></source><year>2014</year><volume>6</volume><issue>5</issue><fpage>1993</fpage><lpage>2022</lpage><pub-id pub-id-type="doi">10.3390/nu6051993</pub-id><pub-id pub-id-type="other">2-s2.0-84901313698</pub-id><?supplied-pmid 24853887?><pub-id pub-id-type="pmid">24853887</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname><given-names>J. M.</given-names></name><name><surname>Sorg</surname><given-names>H.</given-names></name></person-group><article-title>Wound repair and regeneration</article-title><source><italic>European Surgical Research</italic></source><year>2012</year><volume>49</volume><issue>1</issue><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1159/000339613</pub-id><pub-id pub-id-type="other">2-s2.0-84863748841</pub-id><?supplied-pmid 22797712?><pub-id pub-id-type="pmid">22797712</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLeod</surname><given-names>A. S.</given-names></name><name><surname>Mansbridge</surname><given-names>J. N.</given-names></name></person-group><article-title>The innate immune system in acute and chronic wounds</article-title><source><italic>Advances in Wound Care</italic></source><year>2016</year><volume>5</volume><issue>2</issue><fpage>65</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1089/wound.2014.0608</pub-id><?supplied-pmid 26862464?><pub-id pub-id-type="pmid">26862464</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>A. L.</given-names></name><name><surname>Sommer</surname><given-names>K.</given-names></name><name><surname>Neumayer</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Soluble epoxide hydrolase disruption as therapeutic target for wound healing</article-title><source><italic>Journal of Surgical Research</italic></source><year>2013</year><volume>182</volume><issue>2</issue><fpage>362</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2012.10.034</pub-id><pub-id pub-id-type="other">2-s2.0-84877696176</pub-id><?supplied-pmid 23122666?><pub-id pub-id-type="pmid">23122666</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;rbrink</surname><given-names>K.</given-names></name><name><surname>Ni</surname><given-names>G.</given-names></name><name><surname>S&#x000f6;nnergren</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Prevalence and incidence of chronic wounds and related complications: a protocol for a systematic review</article-title><source><italic>Systematic Reviews</italic></source><year>2016</year><volume>5</volume><issue>1</issue><fpage>p. 152</fpage><pub-id pub-id-type="doi">10.1186/s13643-016-0329-y</pub-id><pub-id pub-id-type="other">2-s2.0-84986275965</pub-id><?supplied-pmid 27609108?><pub-id pub-id-type="pmid">27609108</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>C. K.</given-names></name><name><surname>Gordillo</surname><given-names>G. M.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Human skin wounds: a major and snowballing threat to public health and the economy</article-title><source><italic>Wound Repair and Regeneration</italic></source><year>2009</year><volume>17</volume><issue>6</issue><fpage>763</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2009.00543.x</pub-id><pub-id pub-id-type="other">2-s2.0-70350680485</pub-id><?supplied-pmid 19903300?><pub-id pub-id-type="pmid">19903300</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frykberg</surname><given-names>R. G.</given-names></name><name><surname>Banks</surname><given-names>J.</given-names></name></person-group><article-title>Challenges in the treatment of chronic wounds</article-title><source><italic>Advances in Wound Care</italic></source><year>2015</year><volume>4</volume><issue>9</issue><fpage>560</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1089/wound.2015.0635</pub-id><?supplied-pmid 26339534?><pub-id pub-id-type="pmid">26339534</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copeland</surname><given-names>K.</given-names></name><name><surname>Purvis</surname><given-names>A. R.</given-names></name></person-group><article-title>A retrospective chart review of chronic wound patients treated with topical oxygen therapy</article-title><source><italic>Advances in Wound Care</italic></source><year>2017</year><volume>6</volume><issue>5</issue><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1089/wound.2017.0729</pub-id><?supplied-pmid 28507785?><pub-id pub-id-type="pmid">28507785</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>K.</given-names></name><name><surname>Augustin</surname><given-names>M.</given-names></name><name><surname>Protz</surname><given-names>K.</given-names></name><name><surname>Herberger</surname><given-names>K.</given-names></name><name><surname>Spehr</surname><given-names>C.</given-names></name><name><surname>Rustenbach</surname><given-names>S. J.</given-names></name></person-group><article-title>Effectiveness of advanced versus conventional wound dressings on healing of chronic wounds: systematic review and meta-analysis</article-title><source><italic>Dermatology</italic></source><year>2013</year><volume>226</volume><issue>2</issue><fpage>172</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1159/000348331</pub-id><pub-id pub-id-type="other">2-s2.0-84879603973</pub-id><?supplied-pmid 23711429?><pub-id pub-id-type="pmid">23711429</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wicke</surname><given-names>C.</given-names></name><name><surname>Bachinger</surname><given-names>A.</given-names></name><name><surname>Coerper</surname><given-names>S.</given-names></name><name><surname>Beckert</surname><given-names>S.</given-names></name><name><surname>Witte</surname><given-names>M. B.</given-names></name><name><surname>K&#x000f6;nigsrainer</surname><given-names>A.</given-names></name></person-group><article-title>Aging influences wound healing in patients with chronic lower extremity wounds treated in a specialized wound care center</article-title><source><italic>Wound Repair and Regeneration</italic></source><year>2009</year><volume>17</volume><issue>1</issue><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/j.1524-475X.2008.00438.x</pub-id><pub-id pub-id-type="other">2-s2.0-58449125450</pub-id><?supplied-pmid 19152648?><pub-id pub-id-type="pmid">19152648</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Dipietro</surname><given-names>L. A.</given-names></name></person-group><article-title>Factors affecting wound healing</article-title><source><italic>Journal of Dental Research</italic></source><year>2010</year><volume>89</volume><issue>3</issue><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1177/0022034509359125</pub-id><pub-id pub-id-type="other">2-s2.0-77749260633</pub-id><?supplied-pmid 20139336?><pub-id pub-id-type="pmid">20139336</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>K.</given-names></name><name><surname>Hamm</surname><given-names>R. L.</given-names></name></person-group><article-title>Factors that impair wound healing</article-title><source><italic>Journal of the American College of Clinical Wound Specialists</italic></source><year>2012</year><volume>4</volume><issue>4</issue><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.jccw.2014.03.001</pub-id><pub-id pub-id-type="other">2-s2.0-84901003835</pub-id><?supplied-pmid 26199879?><pub-id pub-id-type="pmid">26199879</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okonkwo</surname><given-names>U.</given-names></name><name><surname>DiPietro</surname><given-names>L.</given-names></name></person-group><article-title>Diabetes and wound angiogenesis</article-title><source><italic>International Journal of Molecular Sciences</italic></source><year>2017</year><volume>18</volume><issue>7</issue><fpage>p. 1419</fpage><pub-id pub-id-type="doi">10.3390/ijms18071419</pub-id><pub-id pub-id-type="other">2-s2.0-85022001861</pub-id><?supplied-pmid 28671607?><pub-id pub-id-type="pmid">28671607</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ennis</surname><given-names>W. J.</given-names></name><name><surname>Sui</surname><given-names>A.</given-names></name><name><surname>Bartholomew</surname><given-names>A.</given-names></name></person-group><article-title>Stem cells and healing: impact on inflammation</article-title><source><italic>Advances in Wound Care</italic></source><year>2013</year><volume>2</volume><issue>7</issue><fpage>369</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1089/wound.2013.0449</pub-id><?supplied-pmid 24587974?><pub-id pub-id-type="pmid">24587974</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>L.</given-names></name><name><surname>Bhaumik</surname><given-names>E.</given-names></name><name><surname>Raychaudhuri</surname><given-names>U.</given-names></name><name><surname>Chakraborty</surname><given-names>R.</given-names></name></person-group><article-title>Role of nutraceuticals in human health</article-title><source><italic>Journal of Food Science and Technology</italic></source><year>2012</year><volume>49</volume><issue>2</issue><fpage>173</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1007/s13197-011-0269-4</pub-id><pub-id pub-id-type="other">2-s2.0-84862164586</pub-id><?supplied-pmid 23572839?><pub-id pub-id-type="pmid">23572839</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>P. C.</given-names></name></person-group><article-title>Fatty acids and inflammation: the cutting edge between food and pharma</article-title><source><italic>European Journal of Pharmacology</italic></source><year>2011</year><volume>668</volume><issue>Supplement 1</issue><fpage>S50</fpage><lpage>S58</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2011.05.085</pub-id><pub-id pub-id-type="other">2-s2.0-80055019374</pub-id><?supplied-pmid 21816146?><pub-id pub-id-type="pmid">21816146</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kepler</surname><given-names>C. R.</given-names></name><name><surname>Hirons</surname><given-names>K. P.</given-names></name><name><surname>McNeill</surname><given-names>J.</given-names></name><name><surname>Tove</surname><given-names>S. B.</given-names></name></person-group><article-title>Intermediates and products of the biohydrogenation of linoleic acid by <italic>Butyrinvibrio fibrisolvens</italic></article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1966</year><volume>241</volume><issue>6</issue><fpage>1350</fpage><lpage>1354</lpage><?supplied-pmid 5936712?><pub-id pub-id-type="pmid">5936712</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>J. W.</given-names></name><name><surname>Supp</surname><given-names>D. M.</given-names></name></person-group><article-title>Role of arginine and omega-3 fatty acids in wound healing and infection</article-title><source><italic>Advances in Wound Care</italic></source><year>2014</year><volume>3</volume><issue>11</issue><fpage>682</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1089/wound.2013.0469</pub-id><?supplied-pmid 25371851?><pub-id pub-id-type="pmid">25371851</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>P. C.</given-names></name></person-group><article-title>Omega-3 fatty acids and inflammatory processes</article-title><source><italic>Nutrients</italic></source><year>2010</year><volume>2</volume><issue>3</issue><fpage>355</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.3390/nu2030355</pub-id><pub-id pub-id-type="other">2-s2.0-79952022410</pub-id><?supplied-pmid 22254027?><pub-id pub-id-type="pmid">22254027</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCusker</surname><given-names>M. M.</given-names></name><name><surname>Grant-Kels</surname><given-names>J. M.</given-names></name></person-group><article-title>Healing fats of the skin: the structural and immunologic roles of the <italic>&#x003c9;</italic>-6 and <italic>&#x003c9;</italic>-3 fatty acids</article-title><source><italic>Clinics in Dermatology</italic></source><year>2010</year><volume>28</volume><issue>4</issue><fpage>440</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2010.03.020</pub-id><pub-id pub-id-type="other">2-s2.0-77953971913</pub-id><?supplied-pmid 20620762?><pub-id pub-id-type="pmid">20620762</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>H. G.</given-names></name><name><surname>Vinolo</surname><given-names>M. A. R.</given-names></name><name><surname>Sato</surname><given-names>F. T.</given-names></name><etal/></person-group><article-title>Oral administration of linoleic acid induces new vessel formation and improves skin wound healing in diabetic rats</article-title><source><italic>PloS One</italic></source><year>2016</year><volume>11</volume><issue>10, article e0165115</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0165115</pub-id><pub-id pub-id-type="other">2-s2.0-84992125811</pub-id><?supplied-pmid 27764229?><pub-id pub-id-type="pmid">27764229</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>N.</given-names></name><name><surname>Chugh</surname><given-names>V.</given-names></name><name><surname>Gupta</surname><given-names>A. K.</given-names></name></person-group><article-title>Essential fatty acids as functional components of foods-a review</article-title><source><italic>Journal of Food Science and Technology</italic></source><year>2014</year><volume>51</volume><issue>10</issue><fpage>2289</fpage><lpage>2303</lpage><pub-id pub-id-type="doi">10.1007/s13197-012-0677-0</pub-id><pub-id pub-id-type="other">2-s2.0-84908294658</pub-id><?supplied-pmid 25328170?><pub-id pub-id-type="pmid">25328170</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Declair</surname><given-names>V.</given-names></name></person-group><article-title>The usefulness of topical application of essential fatty acids (EFA) to prevent pressure ulcers</article-title><source><italic>Ostomy/Wound Management</italic></source><year>1997</year><volume>43</volume><issue>5</issue><fpage>48</fpage><lpage>52</lpage><?supplied-pmid 9233238?><pub-id pub-id-type="pmid">9233238</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalh&#x000e3;es</surname><given-names>M. S. F.</given-names></name><name><surname>Fechine</surname><given-names>F. V.</given-names></name><name><surname>de Macedo</surname><given-names>R. N.</given-names></name><etal/></person-group><article-title>Effect of a combination of medium chain triglycerides, linoleic acid, soy lecithin and vitamins A and E on wound healing in rats</article-title><source><italic>Acta Cirurgica Brasileira</italic></source><year>2008</year><volume>23</volume><issue>3</issue><fpage>262</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1590/S0102-86502008000300009</pub-id><pub-id pub-id-type="other">2-s2.0-46849108704</pub-id><?supplied-pmid 18552998?><pub-id pub-id-type="pmid">18552998</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojo</surname><given-names>L. E.</given-names></name><name><surname>Villano</surname><given-names>C. M.</given-names></name><name><surname>Joseph</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Wound-healing properties of nut oil from <italic>Pouteria lucuma</italic></article-title><source><italic>Journal of Cosmetic Dermatology</italic></source><year>2010</year><volume>9</volume><issue>3</issue><fpage>185</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1111/j.1473-2165.2010.00509.x</pub-id><pub-id pub-id-type="other">2-s2.0-77956235633</pub-id><?supplied-pmid 20883291?><pub-id pub-id-type="pmid">20883291</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardaa</surname><given-names>S.</given-names></name><name><surname>Ben Halima</surname><given-names>N.</given-names></name><name><surname>Aloui</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Oil from pumpkin (<italic>Cucurbita pepo</italic> L.) seeds: evaluation of its functional properties on wound healing in rats</article-title><source><italic>Lipids in Health and Disease</italic></source><year>2016</year><volume>15</volume><issue>1</issue><fpage>p. 73</fpage><pub-id pub-id-type="doi">10.1186/s12944-016-0237-0</pub-id><pub-id pub-id-type="other">2-s2.0-84963799684</pub-id><?supplied-pmid 27068642?><pub-id pub-id-type="pmid">27068642</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P.</given-names></name></person-group><article-title>Mechanisms of angiogenesis and arteriogenesis</article-title><source><italic>Nature Medicine</italic></source><year>2000</year><volume>6</volume><issue>4</issue><fpage>389</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/74651</pub-id><pub-id pub-id-type="other">2-s2.0-0034076189</pub-id><?supplied-pmid 10742145?><pub-id pub-id-type="pmid">10742145</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>C. R. B.</given-names></name><name><surname>Souza</surname><given-names>M. A.</given-names></name><name><surname>Ferro</surname><given-names>E. A. V.</given-names></name><name><surname>Favoreto</surname><given-names>S.</given-names></name><name><surname>Pena</surname><given-names>J. D. O.</given-names></name></person-group><article-title>Influence of topical administration of n-3 and n-6 essential and n-9 nonessential fatty acids on the healing of cutaneous wounds</article-title><source><italic>Wound Repair and Regeneration</italic></source><year>2004</year><volume>12</volume><issue>2</issue><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1111/j.1067-1927.2004.012216.x</pub-id><pub-id pub-id-type="other">2-s2.0-1942436963</pub-id><pub-id pub-id-type="pmid">15086775</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000ed;te&#x0010d;ek</surname><given-names>J.</given-names></name><name><surname>Lojek</surname><given-names>A.</given-names></name><name><surname>Valacchi</surname><given-names>G.</given-names></name><name><surname>Kubala</surname><given-names>L.</given-names></name></person-group><article-title>Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges</article-title><source><italic>Mediators of Inflammation</italic></source><year>2012</year><volume>2012</volume><fpage>22</fpage><pub-id pub-id-type="publisher-id">318087</pub-id><pub-id pub-id-type="doi">10.1155/2012/318087</pub-id><pub-id pub-id-type="other">2-s2.0-84867817981</pub-id><?supplied-pmid 22988346?><pub-id pub-id-type="pmid">22988346</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>S.</given-names></name><name><surname>K&#x000e4;mpfer</surname><given-names>H.</given-names></name><name><surname>Wetzler</surname><given-names>C.</given-names></name><name><surname>Pfeilschifter</surname><given-names>J.</given-names></name></person-group><article-title>Nitric oxide drives skin repair: novel functions of an established mediator</article-title><source><italic>Kidney International</italic></source><year>2002</year><volume>61</volume><issue>3</issue><fpage>882</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00237.x</pub-id><pub-id pub-id-type="other">2-s2.0-0036185991</pub-id><?supplied-pmid 11849442?><pub-id pub-id-type="pmid">11849442</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>L. M.</given-names></name><name><surname>Hatanaka</surname><given-names>E.</given-names></name><name><surname>Martins</surname><given-names>E. F.</given-names></name><etal/></person-group><article-title>Effect of oleic and linoleic acids on the inflammatory phase of wound healing in rats</article-title><source><italic>Cell Biochemistry and Function</italic></source><year>2008</year><volume>26</volume><issue>2</issue><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1002/cbf.1432</pub-id><pub-id pub-id-type="other">2-s2.0-40649112864</pub-id><?supplied-pmid 17918246?><pub-id pub-id-type="pmid">17918246</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>H. G.</given-names></name><name><surname>Vinolo</surname><given-names>M. A. R.</given-names></name><name><surname>Magdalon</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Oral administration of oleic or linoleic acid accelerates the inflammatory phase of wound healing</article-title><source><italic>Journal of Investigative Dermatology</italic></source><year>2012</year><volume>132</volume><issue>1</issue><fpage>208</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/jid.2011.265</pub-id><pub-id pub-id-type="other">2-s2.0-84856095235</pub-id><?supplied-pmid 21881592?><pub-id pub-id-type="pmid">21881592</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gealekman</surname><given-names>O.</given-names></name><name><surname>Burkart</surname><given-names>A.</given-names></name><name><surname>Chouinard</surname><given-names>M.</given-names></name><name><surname>Nicoloro</surname><given-names>S. M.</given-names></name><name><surname>Straubhaar</surname><given-names>J.</given-names></name><name><surname>Corvera</surname><given-names>S.</given-names></name></person-group><article-title>Enhanced angiogenesis in obesity and in response to PPAR<italic>&#x003b3;</italic> activators through adipocyte VEGF and ANGPTL4 production</article-title><source><italic>American Journal of Physiology-Endocrinology and Metabolism</italic></source><year>2008</year><volume>295</volume><issue>5</issue><fpage>E1056</fpage><lpage>E1064</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.90345.2008</pub-id><pub-id pub-id-type="other">2-s2.0-57049122852</pub-id><?supplied-pmid 18728224?><pub-id pub-id-type="pmid">18728224</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayadas</surname><given-names>T. N.</given-names></name><name><surname>Cullere</surname><given-names>X.</given-names></name><name><surname>Lowell</surname><given-names>C. A.</given-names></name></person-group><article-title>The multifaceted functions of neutrophils</article-title><source><italic>Annual Review of Pathology</italic></source><year>2014</year><volume>9</volume><issue>1</issue><fpage>181</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-020712-164023</pub-id><pub-id pub-id-type="other">2-s2.0-84896051709</pub-id><?supplied-pmid 24050624?><pub-id pub-id-type="pmid">24050624</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>H. G.</given-names></name><name><surname>Vinolo</surname><given-names>M. A. R.</given-names></name><name><surname>Magdalon</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Dietary free oleic and linoleic acid enhances neutrophil function and modulates the inflammatory response in rats</article-title><source><italic>Lipids</italic></source><year>2010</year><volume>45</volume><issue>9</issue><fpage>809</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1007/s11745-010-3461-9</pub-id><pub-id pub-id-type="other">2-s2.0-77957565854</pub-id><?supplied-pmid 20730605?><pub-id pub-id-type="pmid">20730605</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatanaka</surname><given-names>E.</given-names></name><name><surname>Levada-Pires</surname><given-names>A. C.</given-names></name><name><surname>Pithon-Curi</surname><given-names>T. C.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name></person-group><article-title>Systematic study on ROS production induced by oleic, linoleic, and <italic>&#x003b3;</italic>-linolenic acids in human and rat neutrophils</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2006</year><volume>41</volume><issue>7</issue><fpage>1124</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.06.014</pub-id><pub-id pub-id-type="other">2-s2.0-33748425456</pub-id><?supplied-pmid 16962937?><pub-id pub-id-type="pmid">16962937</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>M.</given-names></name><name><surname>Werner</surname><given-names>S.</given-names></name></person-group><article-title>Oxidative stress in normal and impaired wound repair</article-title><source><italic>Pharmacological Research</italic></source><year>2008</year><volume>58</volume><issue>2</issue><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2008.06.004</pub-id><pub-id pub-id-type="other">2-s2.0-53249117183</pub-id><?supplied-pmid 18617006?><pub-id pub-id-type="pmid">18617006</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Khanna</surname><given-names>S.</given-names></name><name><surname>Nallu</surname><given-names>K.</given-names></name><name><surname>Hunt</surname><given-names>T. K.</given-names></name><name><surname>Sen</surname><given-names>C. K.</given-names></name></person-group><article-title>Dermal wound healing is subject to redox control</article-title><source><italic>Molecular Therapy</italic></source><year>2006</year><volume>13</volume><issue>1</issue><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2005.07.684</pub-id><pub-id pub-id-type="other">2-s2.0-28844474578</pub-id><?supplied-pmid 16126008?><pub-id pub-id-type="pmid">16126008</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>M. J.</given-names></name><name><surname>Liu</surname><given-names>Z.-g.</given-names></name></person-group><article-title>Crosstalk of reactive oxygen species and NF-<italic>&#x003ba;</italic>B signaling</article-title><source><italic>Cell Research</italic></source><year>2011</year><volume>21</volume><issue>1</issue><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1038/cr.2010.178</pub-id><pub-id pub-id-type="other">2-s2.0-78650894319</pub-id><?supplied-pmid 21187859?><pub-id pub-id-type="pmid">21187859</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobar</surname><given-names>N.</given-names></name><name><surname>C&#x000e1;ceres</surname><given-names>M.</given-names></name><name><surname>Santib&#x000e1;&#x000f1;ez</surname><given-names>J. F.</given-names></name><name><surname>Smith</surname><given-names>P. C.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J.</given-names></name></person-group><article-title>RAC1 activity and intracellular ROS modulate the migratory potential of MCF-7 cells through a NADPH oxidase and NF-<italic>&#x003ba;</italic>B-dependent mechanism</article-title><source><italic>Cancer Letters</italic></source><year>2008</year><volume>267</volume><issue>1</issue><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2008.03.011</pub-id><pub-id pub-id-type="other">2-s2.0-45849152081</pub-id><?supplied-pmid 18433991?><pub-id pub-id-type="pmid">18433991</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>D.</given-names></name><name><surname>Ybanez</surname><given-names>M. D.</given-names></name><name><surname>Ahmadi</surname><given-names>S.</given-names></name><name><surname>Yeh</surname><given-names>K.</given-names></name><name><surname>Kaplowitz</surname><given-names>N.</given-names></name></person-group><article-title>Redox regulation of tumor necrosis factor signaling</article-title><source><italic>Antioxidants &#x00026; Redox Signaling</italic></source><year>2009</year><volume>11</volume><issue>9</issue><fpage>2245</fpage><lpage>2263</lpage><pub-id pub-id-type="doi">10.1089/ars.2009.2611</pub-id><pub-id pub-id-type="other">2-s2.0-68949213938</pub-id><?supplied-pmid 19361274?><pub-id pub-id-type="pmid">19361274</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magdalon</surname><given-names>J.</given-names></name><name><surname>Vinolo</surname><given-names>M. A. R.</given-names></name><name><surname>Rodrigues</surname><given-names>H. G.</given-names></name><etal/></person-group><article-title>Oral administration of oleic or linoleic acids modulates the production of inflammatory mediators by rat macrophages</article-title><source><italic>Lipids</italic></source><year>2012</year><volume>47</volume><issue>8</issue><fpage>803</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1007/s11745-012-3687-9</pub-id><pub-id pub-id-type="other">2-s2.0-84864335014</pub-id><?supplied-pmid 22695743?><pub-id pub-id-type="pmid">22695743</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frieder</surname><given-names>J.</given-names></name><name><surname>Kivelevitch</surname><given-names>D.</given-names></name><name><surname>Fiore</surname><given-names>C. T.</given-names></name><name><surname>Saad</surname><given-names>S.</given-names></name><name><surname>Menter</surname><given-names>A.</given-names></name></person-group><article-title>The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis</article-title><source><italic>Expert Review of Clinical Immunology</italic></source><year>2017</year><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1080/1744666X.2018.1401468</pub-id><pub-id pub-id-type="other">2-s2.0-85037745916</pub-id><?supplied-pmid 29110556?><pub-id pub-id-type="pmid">29110556</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>C. N.</given-names></name></person-group><article-title>Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology</article-title><source><italic>Molecular Aspects of Medicine</italic></source><year>2017</year><volume>58</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2017.03.001</pub-id><pub-id pub-id-type="other">2-s2.0-85015305830</pub-id><?supplied-pmid 28263773?><pub-id pub-id-type="pmid">28263773</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastar</surname><given-names>I.</given-names></name><name><surname>Stojadinovic</surname><given-names>O.</given-names></name><name><surname>Yin</surname><given-names>N. C.</given-names></name><etal/></person-group><article-title>Epithelialization in wound healing: a comprehensive review</article-title><source><italic>Advances in Wound Care</italic></source><year>2014</year><volume>3</volume><issue>7</issue><fpage>445</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1089/wound.2013.0473</pub-id><?supplied-pmid 25032064?><pub-id pub-id-type="pmid">25032064</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Shi-wen</surname><given-names>X.</given-names></name><name><surname>Kennedy</surname><given-names>L.</given-names></name><etal/></person-group><article-title>FAK is required for TGF<italic>&#x003b2;</italic>-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype</article-title><source><italic>Molecular Biology of the Cell</italic></source><year>2007</year><volume>18</volume><issue>6</issue><fpage>2169</fpage><lpage>2178</lpage><pub-id pub-id-type="doi">10.1091/mbc.E06-12-1121</pub-id><pub-id pub-id-type="other">2-s2.0-34250376057</pub-id><?supplied-pmid 17409352?><pub-id pub-id-type="pmid">17409352</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinolo</surname><given-names>M. A. R.</given-names></name><name><surname>Hirabara</surname><given-names>S. M.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name></person-group><article-title>G-protein-coupled receptors as fat sensors</article-title><source><italic>Current Opinion in Clinical Nutrition and Metabolic Care</italic></source><year>2012</year><volume>15</volume><issue>2</issue><fpage>112</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e32834f4598</pub-id><pub-id pub-id-type="other">2-s2.0-84857041125</pub-id><?supplied-pmid 22234165?><pub-id pub-id-type="pmid">22234165</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briscoe</surname><given-names>C. P.</given-names></name><name><surname>Tadayyon</surname><given-names>M.</given-names></name><name><surname>Andrews</surname><given-names>J. L.</given-names></name><etal/></person-group><article-title>The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2003</year><volume>278</volume><issue>13</issue><fpage>11303</fpage><lpage>11311</lpage><pub-id pub-id-type="doi">10.1074/jbc.M211495200</pub-id><pub-id pub-id-type="other">2-s2.0-0037838892</pub-id><?supplied-pmid 12496284?><pub-id pub-id-type="pmid">12496284</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartorius</surname><given-names>T.</given-names></name><name><surname>Drescher</surname><given-names>A.</given-names></name><name><surname>Panse</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Mice lacking free fatty acid receptor 1 (GPR40/FFAR1) are protected against conjugated linoleic acid-induced fatty liver but develop inflammation and insulin resistance in the brain</article-title><source><italic>Cellular Physiology and Biochemistry</italic></source><year>2015</year><volume>35</volume><issue>6</issue><fpage>2272</fpage><lpage>2284</lpage><pub-id pub-id-type="doi">10.1159/000374031</pub-id><pub-id pub-id-type="other">2-s2.0-84928157716</pub-id><?supplied-pmid 25895678?><pub-id pub-id-type="pmid">25895678</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Matsuoka</surname><given-names>T.</given-names></name><name><surname>Honda</surname><given-names>T.</given-names></name><name><surname>Kabashima</surname><given-names>K.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Narumiya</surname><given-names>S.</given-names></name></person-group><article-title>A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation</article-title><source><italic>Journal of Investigative Dermatology</italic></source><year>2011</year><volume>131</volume><issue>8</issue><fpage>1660</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1038/jid.2011.123</pub-id><pub-id pub-id-type="other">2-s2.0-79960339155</pub-id><?supplied-pmid 21593768?><pub-id pub-id-type="pmid">21593768</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Parodi</surname><given-names>P. W.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Yuramecz</surname><given-names>M. P.</given-names></name><name><surname>Mossoba</surname><given-names>M. M.</given-names></name><name><surname>Kramer</surname><given-names>J. K. G.</given-names></name><name><surname>Pariza</surname><given-names>M. W.</given-names></name><name><surname>Nelson</surname><given-names>G. J.</given-names></name></person-group><article-title>Conjugated linoleic acid: the early years</article-title><source><italic>Advances in Conjugated Linoleic Acid Research Volume I</italic></source><year>1999</year><publisher-loc>Champaing, IL</publisher-loc><publisher-name>AOCS Press</publisher-name><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>M. H.</given-names></name><name><surname>Miller</surname><given-names>J. R.</given-names></name><name><surname>Mitchell</surname><given-names>P. L.</given-names></name><name><surname>Currie</surname><given-names>D. L.</given-names></name><name><surname>McLeod</surname><given-names>R. S.</given-names></name></person-group><article-title>Conjugated linoleic acid isomers have no effect on atherosclerosis and adverse effects on lipoprotein and liver lipid metabolism in apoE<sup>&#x02212;/&#x02212;</sup> mice fed a high-cholesterol diet</article-title><source><italic>Atherosclerosis</italic></source><year>2008</year><volume>200</volume><issue>2</issue><fpage>294</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2007.12.040</pub-id><pub-id pub-id-type="other">2-s2.0-52149083045</pub-id><?supplied-pmid 18280484?><pub-id pub-id-type="pmid">18280484</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>A.</given-names></name><name><surname>Banu</surname><given-names>J.</given-names></name><name><surname>Rahman</surname><given-names>M.</given-names></name><name><surname>Causey</surname><given-names>J.</given-names></name><name><surname>Fernandes</surname><given-names>G.</given-names></name></person-group><article-title>Biological effects of conjugated linoleic acids in health and disease</article-title><source><italic>The Journal of Nutritional Biochemistry</italic></source><year>2006</year><volume>17</volume><issue>12</issue><fpage>789</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2006.02.009</pub-id><pub-id pub-id-type="other">2-s2.0-33750935990</pub-id><?supplied-pmid 16650752?><pub-id pub-id-type="pmid">16650752</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Whang</surname><given-names>K. Y.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name></person-group><article-title>Impact of conjugated linoleic acid (CLA) on skeletal muscle metabolism</article-title><source><italic>Lipids</italic></source><year>2016</year><volume>51</volume><issue>2</issue><fpage>159</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1007/s11745-015-4115-8</pub-id><pub-id pub-id-type="other">2-s2.0-84957426416</pub-id><?supplied-pmid 26729488?><pub-id pub-id-type="pmid">26729488</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>R.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group><article-title>Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids</article-title><source><italic>Nutrition Reviews</italic></source><year>2010</year><volume>68</volume><issue>5</issue><fpage>280</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2010.00287.x</pub-id><pub-id pub-id-type="other">2-s2.0-77953904162</pub-id><?supplied-pmid 20500789?><pub-id pub-id-type="pmid">20500789</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viladomiu</surname><given-names>M.</given-names></name><name><surname>Hontecillas</surname><given-names>R.</given-names></name><name><surname>Bassaganya-Riera</surname><given-names>J.</given-names></name></person-group><article-title>Modulation of inflammation and immunity by dietary conjugated linoleic acid</article-title><source><italic>European Journal of Pharmacology</italic></source><year>2016</year><volume>785</volume><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.03.095</pub-id><pub-id pub-id-type="other">2-s2.0-84929915689</pub-id><?supplied-pmid 25987426?><pub-id pub-id-type="pmid">25987426</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Chardigny</surname><given-names>J. M.</given-names></name><name><surname>Bauchart</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Butters rich either in <italic>trans</italic>-10-C18:1 or in <italic>trans</italic>-11-C18:1 plus <italic>cis</italic>-9, <italic>trans</italic>-11 CLA differentially affect plasma lipids and aortic fatty streak in experimental atherosclerosis in rabbits</article-title><source><italic>Animal</italic></source><year>2007</year><volume>1</volume><issue>3</issue><fpage>467</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1017/S175173110770530X</pub-id><pub-id pub-id-type="other">2-s2.0-34047105380</pub-id><?supplied-pmid 22444345?><pub-id pub-id-type="pmid">22444345</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oleszczuk</surname><given-names>J.</given-names></name><name><surname>Oleszczuk</surname><given-names>L.</given-names></name><name><surname>Siwicki</surname><given-names>A. K.</given-names></name><name><surname>Skopi&#x00144;ska-Skopi&#x00144;ska</surname><given-names>E.</given-names></name></person-group><article-title>Biological effects of conjugated linoleic acids supplementation</article-title><source><italic>Polish Journal of Veterinary Sciences</italic></source><year>2012</year><volume>15</volume><issue>2</issue><fpage>403</fpage><lpage>408</lpage><?supplied-pmid 22844724?><pub-id pub-id-type="pmid">22844724</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>N. Y.</given-names></name><name><surname>Valacchi</surname><given-names>G.</given-names></name><name><surname>Lim</surname><given-names>Y.</given-names></name></person-group><article-title>Effect of dietary conjugated linoleic acid supplementation on early inflammatory responses during cutaneous wound healing</article-title><source><italic>Mediators of Inflammation</italic></source><year>2010</year><volume>2010</volume><fpage>8</fpage><pub-id pub-id-type="publisher-id">342328</pub-id><pub-id pub-id-type="doi">10.1155/2010/342328</pub-id><pub-id pub-id-type="other">2-s2.0-77956831274</pub-id><?supplied-pmid 20871865?><pub-id pub-id-type="pmid">20871865</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zhong</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Acute hypoxia induced an imbalanced M1/M2 activation of microglia through NF-<italic>&#x003ba;</italic>B signaling in Alzheimer&#x02019;s disease mice and wild-type littermates</article-title><source><italic>Frontiers in Aging Neuroscience</italic></source><year>2017</year><volume>9</volume><fpage>p. 282</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2017.00282</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>D.-M.</given-names></name><name><surname>Kundu</surname><given-names>J. K.</given-names></name><name><surname>Shin</surname><given-names>J.-W.</given-names></name><name><surname>Lee</surname><given-names>J.-C.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Surh</surname><given-names>Y.-J.</given-names></name></person-group><article-title>
<italic>cis</italic>-9, <italic>trans</italic>-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-<italic>&#x003ba;</italic>B activation and subsequent COX-2 expression in hairless mouse skin by targeting I<italic>&#x003ba;</italic>B kinase and PI3K-Akt</article-title><source><italic>Carcinogenesis</italic></source><year>2006</year><volume>28</volume><issue>2</issue><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgl151</pub-id><pub-id pub-id-type="other">2-s2.0-33847277462</pub-id><?supplied-pmid 16950795?><pub-id pub-id-type="pmid">16950795</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>T. L.</given-names></name><name><surname>Su</surname><given-names>Y. C.</given-names></name><name><surname>Chang</surname><given-names>H. L.</given-names></name><etal/></person-group><article-title>Suppression of superoxide anion and elastase release by C<sub>18</sub> unsaturated fatty acids in human neutrophils</article-title><source><italic>Journal of Lipid Research</italic></source><year>2009</year><volume>50</volume><issue>7</issue><fpage>1395</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1194/jlr.M800574-JLR200</pub-id><pub-id pub-id-type="other">2-s2.0-67650555702</pub-id><?supplied-pmid 19295184?><pub-id pub-id-type="pmid">19295184</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perdomo</surname><given-names>M. C.</given-names></name><name><surname>Santos</surname><given-names>J. E.</given-names></name><name><surname>Badinga</surname><given-names>L.</given-names></name></person-group><article-title>
<italic>trans</italic>-10, <italic>cis</italic>-12 conjugated linoleic acid and the PPAR-<italic>&#x003b3;</italic> agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-<italic>&#x003b1;</italic> production by bovine immune cells</article-title><source><italic>Domestic Animal Endocrinology</italic></source><year>2011</year><volume>41</volume><issue>3</issue><fpage>118</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.domaniend.2011.05.005</pub-id><pub-id pub-id-type="other">2-s2.0-80052337444</pub-id><?supplied-pmid 21798687?><pub-id pub-id-type="pmid">21798687</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>M. H.</given-names></name><name><surname>Kang</surname><given-names>J. H.</given-names></name><name><surname>Yang</surname><given-names>M. P.</given-names></name></person-group><article-title>Immunoenhancing effect of <italic>trans</italic>-10, <italic>cis</italic>-12 conjugated linoleic acid on the phagocytic capacity and oxidative burst activity of canine peripheral blood phagocytes</article-title><source><italic>Research in Veterinary Science</italic></source><year>2008</year><volume>85</volume><issue>2</issue><fpage>269</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2007.12.005</pub-id><pub-id pub-id-type="other">2-s2.0-45449104040</pub-id><?supplied-pmid 18234254?><pub-id pub-id-type="pmid">18234254</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Kang</surname><given-names>S. B.</given-names></name><name><surname>Park</surname><given-names>W.</given-names></name></person-group><article-title>Fatty acid desaturases, polyunsaturated fatty acid regulation, and biotechnological advances</article-title><source><italic>Nutrients</italic></source><year>2016</year><volume>8</volume><issue>1</issue><pub-id pub-id-type="doi">10.3390/nu8010023</pub-id><pub-id pub-id-type="other">2-s2.0-84954063207</pub-id><?supplied-pmid 26742061?><pub-id pub-id-type="pmid">26742061</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawczynski</surname><given-names>C.</given-names></name><name><surname>Hackermeier</surname><given-names>U.</given-names></name><name><surname>Viehweger</surname><given-names>M.</given-names></name><name><surname>Stange</surname><given-names>R.</given-names></name><name><surname>Springer</surname><given-names>M.</given-names></name><name><surname>Jahreis</surname><given-names>G.</given-names></name></person-group><article-title>Incorporation of n-3 PUFA and <italic>&#x003b3;</italic>-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis - a randomized controlled human intervention trial</article-title><source><italic>Lipids in Health and Disease</italic></source><year>2011</year><volume>10</volume><issue>1</issue><fpage>p. 130</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-130</pub-id><pub-id pub-id-type="other">2-s2.0-79961113494</pub-id><?supplied-pmid 21816071?><pub-id pub-id-type="pmid">21816071</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taweechaisupapong</surname><given-names>S.</given-names></name><name><surname>Srisuk</surname><given-names>N.</given-names></name><name><surname>Nimitpornsuko</surname><given-names>C.</given-names></name><name><surname>Vattraphoudes</surname><given-names>T.</given-names></name><name><surname>Rattanayatikul</surname><given-names>C.</given-names></name><name><surname>Godfrey</surname><given-names>K.</given-names></name></person-group><article-title>Evening primrose oil effects on osteoclasts during tooth movement</article-title><source><italic>The Angle Orthodontist</italic></source><year>2005</year><volume>75</volume><issue>3</issue><fpage>356</fpage><lpage>361</lpage><?supplied-pmid 15898373?><pub-id pub-id-type="pmid">15898373</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olendzki</surname><given-names>B. C.</given-names></name><name><surname>Leung</surname><given-names>K.</given-names></name><name><surname>Van Buskirk</surname><given-names>S.</given-names></name><name><surname>Reed</surname><given-names>G.</given-names></name><name><surname>Zurier</surname><given-names>R. B.</given-names></name></person-group><article-title>Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2011</year><volume>2011</volume><fpage>9</fpage><pub-id pub-id-type="publisher-id">827286</pub-id><pub-id pub-id-type="doi">10.1155/2011/827286</pub-id><pub-id pub-id-type="other">2-s2.0-84855168055</pub-id><?supplied-pmid 22007257?><pub-id pub-id-type="pmid">22007257</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasiljevic</surname><given-names>D.</given-names></name><name><surname>Veselinovic</surname><given-names>M.</given-names></name><name><surname>Jovanovic</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Evaluation of the effects of different supplementation on oxidative status in patients with rheumatoid arthritis</article-title><source><italic>Clinical Rheumatology</italic></source><year>2016</year><volume>35</volume><issue>8</issue><fpage>1909</fpage><lpage>1915</lpage><pub-id pub-id-type="doi">10.1007/s10067-016-3168-2</pub-id><pub-id pub-id-type="other">2-s2.0-84954317083</pub-id><?supplied-pmid 26758438?><pub-id pub-id-type="pmid">26758438</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>R. H.</given-names></name><name><surname>Hardy</surname><given-names>G.</given-names></name><name><surname>Alany</surname><given-names>R. G.</given-names></name></person-group><article-title>Borage oil in the treatment of atopic dermatitis</article-title><source><italic>Nutrition</italic></source><year>2010</year><volume>26</volume><issue>7-8</issue><fpage>708</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2009.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-77953804733</pub-id><?supplied-pmid 20579590?><pub-id pub-id-type="pmid">20579590</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>J. Y.</given-names></name><name><surname>Kwon</surname><given-names>H. H.</given-names></name><name><surname>Hong</surname><given-names>J. S.</given-names></name><etal/></person-group><article-title>Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial</article-title><source><italic>Acta Dermato Venereologica</italic></source><year>2014</year><volume>94</volume><issue>5</issue><fpage>521</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.2340/00015555-1802</pub-id><pub-id pub-id-type="other">2-s2.0-84906062169</pub-id><?supplied-pmid 24553997?><pub-id pub-id-type="pmid">24553997</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>D.</given-names></name><name><surname>Eng</surname><given-names>P. A.</given-names></name><name><surname>Borelli</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Gamma-linolenic acid levels correlate with clinical efficacy of evening primrose oil in patients with atopic dermatitis</article-title><source><italic>Advances in Therapy</italic></source><year>2014</year><volume>31</volume><issue>2</issue><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/s12325-014-0093-0</pub-id><pub-id pub-id-type="other">2-s2.0-84899070410</pub-id><?supplied-pmid 24435467?><pub-id pub-id-type="pmid">24435467</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C. S.</given-names></name><name><surname>Sun</surname><given-names>H. L.</given-names></name><name><surname>Lii</surname><given-names>C. K.</given-names></name><name><surname>Chen</surname><given-names>H. W.</given-names></name><name><surname>Chen</surname><given-names>P. Y.</given-names></name><name><surname>Liu</surname><given-names>K. L.</given-names></name></person-group><article-title>Gamma-linolenic acid inhibits inflammatory responses by regulating NF-<italic>&#x003ba;</italic>B and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages</article-title><source><italic>Inflammation</italic></source><year>2010</year><volume>33</volume><issue>1</issue><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/s10753-009-9157-8</pub-id><pub-id pub-id-type="other">2-s2.0-76149140866</pub-id><?supplied-pmid 19842026?><pub-id pub-id-type="pmid">19842026</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>S. Y.</given-names></name><name><surname>Lee</surname><given-names>S. J.</given-names></name><name><surname>Jung</surname><given-names>Y. H.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Han</surname><given-names>H. J.</given-names></name></person-group><article-title>Arachidonic acid promotes skin wound healing through induction of human MSC migration by MT3-MMP-mediated fibronectin degradation</article-title><source><italic>Cell Death &#x00026; Disease</italic></source><year>2015</year><volume>6</volume><issue>5, article e1750</issue><pub-id pub-id-type="doi">10.1038/cddis.2015.114</pub-id><pub-id pub-id-type="other">2-s2.0-84953371939</pub-id><?supplied-pmid 25950480?><pub-id pub-id-type="pmid">25950480</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuncer</surname><given-names>S.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name></person-group><article-title>Eicosanoid pathway in colorectal cancer: recent updates</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2015</year><volume>21</volume><issue>41</issue><fpage>11748</fpage><lpage>11766</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i41.11748</pub-id><pub-id pub-id-type="other">2-s2.0-84947250881</pub-id><?supplied-pmid 26557000?><pub-id pub-id-type="pmid">26557000</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendall</surname><given-names>A. C.</given-names></name><name><surname>Nicolaou</surname><given-names>A.</given-names></name></person-group><article-title>Bioactive lipid mediators in skin inflammation and immunity</article-title><source><italic>Progress in Lipid Research</italic></source><year>2013</year><volume>52</volume><issue>1</issue><fpage>141</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2012.10.003</pub-id><pub-id pub-id-type="other">2-s2.0-84870223620</pub-id><?supplied-pmid 23124022?><pub-id pub-id-type="pmid">23124022</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivamani</surname><given-names>R. K.</given-names></name></person-group><article-title>Eicosanoids and keratinocytes in wound healing</article-title><source><italic>Advances in Wound Care</italic></source><year>2014</year><volume>3</volume><issue>7</issue><fpage>476</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1089/wound.2014.0523</pub-id><?supplied-pmid 25032067?><pub-id pub-id-type="pmid">25032067</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobi</surname><given-names>S. K.</given-names></name><name><surname>Moeser</surname><given-names>A. J.</given-names></name><name><surname>Corl</surname><given-names>B. A.</given-names></name><name><surname>Harrell</surname><given-names>R. J.</given-names></name><name><surname>Blikslager</surname><given-names>A. T.</given-names></name><name><surname>Odle</surname><given-names>J.</given-names></name></person-group><article-title>Dietary long-chain PUFA enhance acute repair of ischemia-injured intestine of suckling pigs</article-title><source><italic>The Journal of Nutrition</italic></source><year>2012</year><volume>142</volume><issue>7</issue><fpage>1266</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.3945/jn.111.150995</pub-id><pub-id pub-id-type="other">2-s2.0-84863543759</pub-id><?supplied-pmid 22623387?><pub-id pub-id-type="pmid">22623387</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blikslager</surname><given-names>A. T.</given-names></name><name><surname>Moeser</surname><given-names>A. J.</given-names></name><name><surname>Gookin</surname><given-names>J. L.</given-names></name><name><surname>Jones</surname><given-names>S. L.</given-names></name><name><surname>Odle</surname><given-names>J.</given-names></name></person-group><article-title>Restoration of barrier function in injured intestinal mucosa</article-title><source><italic>Physiological Reviews</italic></source><year>2007</year><volume>87</volume><issue>2</issue><fpage>545</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1152/physrev.00012.2006</pub-id><pub-id pub-id-type="other">2-s2.0-34248593791</pub-id><?supplied-pmid 17429041?><pub-id pub-id-type="pmid">17429041</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>K.</given-names></name><name><surname>Tanigami</surname><given-names>M.</given-names></name><name><surname>Amagase</surname><given-names>K.</given-names></name><name><surname>Ochi</surname><given-names>A.</given-names></name><name><surname>Okuda</surname><given-names>S.</given-names></name><name><surname>Hatazawa</surname><given-names>R.</given-names></name></person-group><article-title>Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors</article-title><source><italic>Journal of Gastroenterology and Hepatology</italic></source><year>2010</year><volume>25</volume><fpage>S67</fpage><lpage>S74</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2010.06222.x</pub-id><pub-id pub-id-type="other">2-s2.0-77951586516</pub-id><?supplied-pmid 20586869?><pub-id pub-id-type="pmid">20586869</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naito</surname><given-names>Y.</given-names></name><name><surname>Ji</surname><given-names>X.</given-names></name><name><surname>Tachibana</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Effects of arachidonic acid intake on inflammatory reactions in dextran sodium sulphate-induced colitis in rats</article-title><source><italic>British Journal of Nutrition</italic></source><year>2015</year><volume>114</volume><issue>5</issue><fpage>734</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1017/S000711451500224X</pub-id><pub-id pub-id-type="other">2-s2.0-84940605389</pub-id><pub-id pub-id-type="pmid">26234346</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhall</surname><given-names>S.</given-names></name><name><surname>Wijesinghe</surname><given-names>D. S.</given-names></name><name><surname>Karim</surname><given-names>Z. A.</given-names></name><etal/></person-group><article-title>Arachidonic acid-derived signaling lipids and functions in impaired healing</article-title><source><italic>Wound Repair and Regeneration</italic></source><year>2015</year><volume>23</volume><issue>5</issue><fpage>644</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1111/wrr.12337</pub-id><pub-id pub-id-type="other">2-s2.0-84945458515</pub-id><?supplied-pmid 26135854?><pub-id pub-id-type="pmid">26135854</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panigrahy</surname><given-names>D.</given-names></name><name><surname>Kalish</surname><given-names>B. T.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Epoxyeicosanoids promote organ and tissue regeneration</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2013</year><volume>110</volume><issue>33</issue><fpage>13528</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311565110</pub-id><pub-id pub-id-type="other">2-s2.0-84882380783</pub-id><?supplied-pmid 23898174?><pub-id pub-id-type="pmid">23898174</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossen</surname><given-names>N. S.</given-names></name><name><surname>Hansen</surname><given-names>A. J.</given-names></name><name><surname>Selhuber-Unkel</surname><given-names>C.</given-names></name><name><surname>Oddershede</surname><given-names>L. B.</given-names></name></person-group><article-title>Arachidonic acid randomizes endothelial cell motion and regulates adhesion and migration</article-title><source><italic>PLoS One</italic></source><year>2011</year><volume>6</volume><issue>9, article e25196</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0025196</pub-id><pub-id pub-id-type="other">2-s2.0-80053095835</pub-id><?supplied-pmid 21966453?><pub-id pub-id-type="pmid">21966453</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname><given-names>T.</given-names></name><name><surname>Hosoda</surname><given-names>K.</given-names></name><name><surname>Fujikura</surname><given-names>J.</given-names></name><name><surname>Inagaki</surname><given-names>N.</given-names></name><name><surname>Nakao</surname><given-names>K.</given-names></name></person-group><article-title>The G-protein-coupled long-chain fatty acid receptor GPR40 and glucose metabolism</article-title><source><italic>Frontiers in Endocrinology</italic></source><year>2014</year><volume>5</volume><fpage>p. 152</fpage><pub-id pub-id-type="doi">10.3389/fendo.2014.00152</pub-id><pub-id pub-id-type="other">2-s2.0-84907970684</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Wound healing process. The illustration shows the inflammatory, proliferative, and remodelling phases of wound healing. Early stages of wound healing include coagulation and activation of inflammatory cells. The proliferative stage involves proliferation of fibroblasts and angiogenesis. The remodelling phase includes restoration of the barrier and contraction of the wound by myofibroblasts. The process is orchestrated by immune cells and growth factors and cytokines and chemokines (listed below) [<xref rid="B8" ref-type="bibr">8</xref>]. HF&#x02009;=&#x02009;hair follicle; BV&#x02009;=&#x02009;blood vessels; TNF&#x02009;=&#x02009;tumor necrosis factor; IL-1beta&#x02009;=&#x02009;interleucina 1beta; IL-6&#x02009;=&#x02009;interleucina 6; ROS&#x02009;=&#x02009;reactive oxygen species; CXCL2&#x02009;=&#x02009;chemokine (C-X-C motif) ligand 2; IFN-gamma&#x02009;=&#x02009;interferon-gamma; VEGF&#x02009;=&#x02009;vascular endothelial growth factor; TGF-beta&#x02009;=&#x02009;transforming growth factor beta; FGF&#x02009;=&#x02009;fibroblast growth factor; KGF&#x02009;=&#x000a0;keratinocyte growth factor; MCP1&#x02009;=&#x02009;monocyte chemoattractant protein-1; IGF&#x02009;=&#x02009;insulin growth factor; TIMPs&#x02009;=&#x02009;tissue inhibitors of metalloproteinases; MMPs&#x02009;=&#x02009;matrix matalloproteinases; PDGF&#x02009;=&#x02009;platelet-derived growth factor; EGF&#x02009;=&#x02009;epithelial growth factor.</p></caption><graphic xlink:href="MI2018-2503950.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effects of linoleic acid (LA), conjugated linoleic acid (CLA), gamma linolenic acid (GLA), and arachidonic acid on wound healing phases.</p></caption><graphic xlink:href="MI2018-2503950.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Effects of linoleic (LA) fatty acid.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Fatty acid</th><th align="center" rowspan="1" colspan="1">Condition</th><th align="center" rowspan="1" colspan="1">Study model</th><th align="center" rowspan="1" colspan="1">Treatment time</th><th align="center" rowspan="1" colspan="1">Dose/concentration</th><th align="center" rowspan="1" colspan="1">Molecules associated</th><th align="center" rowspan="1" colspan="1">Effect in tissue repair</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="12" colspan="1">LA</td><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Diabetic Wistar rats</td><td align="center" rowspan="1" colspan="1">18&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.22&#x02009;g/Kg bw (oral administration)</td><td align="center" rowspan="1" colspan="1">Increased VEGF and ANGPT-2</td><td align="center" rowspan="1" colspan="1">Accelerated the inflammatory phase and angiogenesis</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Pressure ulcers</td><td align="center" rowspan="1" colspan="1">Healthy humans</td><td align="center" rowspan="1" colspan="1">21&#x02009;days</td><td align="center" rowspan="1" colspan="1">1.6&#x02009;g EFA with LA extracted from sunflower oil (topical application)</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Increased hydration and elasticity.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Healthy rats</td><td align="center" rowspan="1" colspan="1">12&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.14&#x02009;g solution with TGs, LA, vitamins A and E, and soy lecithin (topical application)</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">No effects</td><td align="center" rowspan="1" colspan="1">[<xref rid="B41" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" rowspan="2" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Zebrafish</td><td align="center" rowspan="1" colspan="1">48&#x02009;hours</td><td align="center" rowspan="1" colspan="1">10&#x02013;100&#x000a0;<italic>&#x003bc;</italic>g/mL of lucuma nut oil</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Improved regeneration (100&#x000a0;<italic>&#x003bc;</italic>g/mL)</td><td align="center" rowspan="2" colspan="1">[<xref rid="B42" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">CD-1 mice</td><td align="center" rowspan="1" colspan="1">11&#x02009;days</td><td align="center" rowspan="1" colspan="1">200, 500, or 1000&#x000a0;<italic>&#x003bc;</italic>g of lucuma nut oil (topical application)</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Improved wound healing and formation of new blood vessels (500 and 1000&#x000a0;<italic>&#x003bc;</italic>g)</td></tr><tr><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Healthy rats</td><td align="center" rowspan="1" colspan="1">11&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.52&#x000a0;<italic>&#x003bc;</italic>L/mm<sup>2</sup> of pumpkin oil (topical application)</td><td align="center" rowspan="1" colspan="1">Increased hydroxyproline content</td><td align="center" rowspan="1" colspan="1">Accelerated wound closure and bleeding time, improved fibrin stabilization, increased migration of fibroblasts, and reduced infiltration of macrophages</td><td align="center" rowspan="1" colspan="1">[<xref rid="B43" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Healthy BALB/c mice</td><td align="center" rowspan="1" colspan="1">20&#x02009;days</td><td align="center" rowspan="1" colspan="1">30&#x000a0;<italic>&#x003bc;</italic>M of pure LA (topical application)</td><td align="center" rowspan="1" colspan="1">Increased NO production</td><td align="center" rowspan="1" colspan="1">Accelerated tissue repair</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Healthy Wistar rats</td><td align="center" rowspan="1" colspan="1">24&#x02009;hours</td><td align="center" rowspan="1" colspan="1">300&#x000a0;<italic>&#x003bc;</italic>L of pure LA (topical application)</td><td align="center" rowspan="1" colspan="1">Increased total protein and DNA contents and elevated VEGF-<italic>&#x003b1;</italic> and IL-1</td><td align="center" rowspan="1" colspan="1">No effect on wound area</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Healthy Wistar rats</td><td align="center" rowspan="1" colspan="1">5&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.22&#x02009;g/Kg bw of pure LA (oral administration)</td><td align="center" rowspan="1" colspan="1">Increased H<sub>2</sub>O<sub>2</sub> and AP-1 and reduced NF-<italic>&#x003ba;</italic>B, IL-1<italic>&#x003b2;</italic>, and IL-6</td><td align="center" rowspan="1" colspan="1">Accelerated the inflammatory phase</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Neutrophil functions</td><td align="center" rowspan="1" colspan="1">Intraperitoneal neutrophils from healthy Wistar rats</td><td align="center" rowspan="1" colspan="1">10&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.11, 0.22, and 0.44&#x02009;g/kg of bw (oral administration)</td><td align="center" rowspan="1" colspan="1">Increased L-selectin, IL-1<italic>&#x003b2;</italic>, and CINC-2<italic>&#x003b1;&#x003b2;</italic></td><td align="center" rowspan="1" colspan="1">Increased leukocyte-endothelium interactions</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Neutrophil functions</td><td align="center" rowspan="1" colspan="1">Intraperitoneal neutrophils from healthy Wistar rats</td><td align="center" rowspan="1" colspan="1">20&#x02009;minutes</td><td align="center" rowspan="1" colspan="1">0, 10, 25, 50, 100, and 200&#x000a0;<italic>&#x003bc;</italic>M <italic>(in vitro)</italic></td><td align="center" rowspan="1" colspan="1">Increased O<sub>2</sub><sup>&#x02212;</sup> and H<sub>2</sub>O<sub>2</sub> (50&#x000a0;<italic>&#x003bc;</italic>M)</td><td align="center" rowspan="1" colspan="1">Increased ROS</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Macrophage functions</td><td align="center" rowspan="1" colspan="1">Macrophages from healthy Wistar rats</td><td align="center" rowspan="1" colspan="1">10&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.22&#x02009;g/Kg bw (oral administration)</td><td align="center" rowspan="1" colspan="1">Reduced IL-6, VEGF, and IL-10</td><td align="center" rowspan="1" colspan="1">Modulated cytokine production by macrophages</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Essential fatty acids (EFA); triglycerides (TGs); nitric oxide (NO); Deoxyribonucleic acid (DNA); vascular endothelial growth factor (VEGF); interleukin-1<italic>&#x003b2;</italic> (IL-1<italic>&#x003b2;</italic>); body weight (bw); hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>); activator protein-1 (AP-1); nuclear transcription factor (NF-<italic>&#x003ba;</italic>B); interleukin-6 (IL-6); angiopoietin-2 (ANGPT-2); cytokine-induced neutrophil chemoattractant-2 (CINC-2<italic>&#x003b1;&#x003b2;</italic>); reactive oxygen species (ROS); lipopolysaccharides (LPS); interleukin-10 (IL-10); not analysed (NA).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Effects of conjugated linoleic acid (CLA).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Fatty acid</th><th align="center" rowspan="1" colspan="1">Condition</th><th align="center" rowspan="1" colspan="1">Study model</th><th align="center" rowspan="1" colspan="1">Treatment time</th><th align="center" rowspan="1" colspan="1">Dose/concentration</th><th align="center" rowspan="1" colspan="1">Molecules associated</th><th align="center" rowspan="1" colspan="1">Effect in tissue repair</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">CLA</td><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">Healthy mice</td><td align="center" rowspan="1" colspan="1">2&#x02009;weeks</td><td align="center" rowspan="1" colspan="1">0.5 or 1% of CLA (diet)</td><td align="center" rowspan="1" colspan="1">Increased CuZnSOD, and MnSOD and reduced pIkB<italic>&#x003b1;</italic>, COX-2, HO-1, and MDA</td><td align="center" rowspan="1" colspan="1">Increased the antioxidant defences and reduced the wound area (1%)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Hairless skin</td><td align="center" rowspan="1" colspan="1">Mice</td><td align="center" rowspan="1" colspan="1">6&#x02009;hours</td><td align="center" rowspan="1" colspan="1">0.25 or 1&#x02009;mg (topical application)</td><td align="center" rowspan="1" colspan="1">Reduced NF-<italic>&#x003ba;</italic>B, COX-2, IKK<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic>, MAPK, and Akt</td><td align="center" rowspan="1" colspan="1">Antitumor (1&#x02009;mg)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B78" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Inflammatory diseases</td><td align="center" rowspan="1" colspan="1">Bovine PBMC</td><td align="center" rowspan="1" colspan="1">24&#x02009;hours</td><td align="center" rowspan="1" colspan="1">100&#x000a0;<italic>&#x003bc;</italic>M <italic>(in vitro)</italic></td><td align="center" rowspan="1" colspan="1">Decreased TNF-<italic>&#x003b1;</italic></td><td align="center" rowspan="1" colspan="1">Additional studies are needed</td><td align="center" rowspan="1" colspan="1">[<xref rid="B80" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Inflammatory diseases</td><td align="center" rowspan="1" colspan="1">Blood phagocytes isolated from dogs</td><td align="center" rowspan="1" colspan="1">24&#x02009;hours</td><td align="center" rowspan="1" colspan="1">10&#x000a0;<italic>&#x003bc;</italic>M <italic>(in vitro)</italic></td><td align="center" rowspan="1" colspan="1">Increased TNF-<italic>&#x003b1;</italic></td><td align="center" rowspan="1" colspan="1">Increased oxidative burst activity and phagocytic capacity</td><td align="center" rowspan="1" colspan="1">[<xref rid="B81" ref-type="bibr">81</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>CuZn superoxide dismutase (CuZnSOD); Mn superoxide dismutase (MnSOD); cicloxigenase-2 (COX-2); malondialdehyde (MDA); nuclear transcription factor (NF-<italic>&#x003ba;</italic>B); I<italic>&#x003ba;</italic>B kinase (IKK<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic>); mitogen-activated protein kinase (MAPK); protein kinase B (Akt); tumor necrosis factor <italic>&#x003b1;</italic> (TNF-<italic>&#x003b1;</italic>); peripheral blood mononuclear cells (PBMC); not analysed (NA).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Effects of gamma linolenic (GLA) fatty acid.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Fatty acid</th><th align="center" rowspan="1" colspan="1">Condition</th><th align="center" rowspan="1" colspan="1">Study model</th><th align="center" rowspan="1" colspan="1">Treatment time</th><th align="center" rowspan="1" colspan="1">Dose/concentration</th><th align="center" rowspan="1" colspan="1">Molecules associated</th><th align="center" rowspan="1" colspan="1">Effect in tissue repair</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">GLA</td><td align="center" rowspan="1" colspan="1">Acne vulgaris</td><td align="center" rowspan="1" colspan="1">Healthy humans</td><td align="center" rowspan="1" colspan="1">10&#x02009;weeks</td><td align="center" rowspan="1" colspan="1">400&#x02009;mg (oral administration)</td><td align="center" rowspan="1" colspan="1">Reduced IL-8</td><td align="center" rowspan="1" colspan="1">Reduced lesion number, severity, and inflammation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B88" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Atopic dermatitis (AD)</td><td align="center" rowspan="1" colspan="1">Humans</td><td align="center" rowspan="1" colspan="1">12 weeks</td><td align="center" rowspan="1" colspan="1">320 or 480&#x02009;mg (oral administration)</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Improvement of clinical signs of AD</td><td align="center" rowspan="1" colspan="1">[<xref rid="B89" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Macrophage functions</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">100 to 200&#x000a0;<italic>&#x003bc;</italic>M <italic>(in vitro)</italic></td><td align="center" rowspan="1" colspan="1">Reduced iNOS, NO, COX-2, pro-IL-1, pI<italic>&#x003ba;</italic>B, and NF-<italic>&#x003ba;</italic>B</td><td align="center" rowspan="1" colspan="1">Decreased inflammation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B90" ref-type="bibr">90</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Interleukin-8 (IL-8); inducible nitric oxide synthase (iNOS); oxide nitric (NO); cicloxigenase-2 (COX-2); prointerleukin-1 (pro-IL-1); nuclear transcription factor (NF-<italic>&#x003ba;</italic>B); not analysed (NA)</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Effects of arachidonic (AA) fatty acid.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Fatty acid</th><th align="center" rowspan="1" colspan="1">Condition</th><th align="center" rowspan="1" colspan="1">Study model</th><th align="center" rowspan="1" colspan="1">Treatment time</th><th align="center" rowspan="1" colspan="1">Dose/concentration</th><th align="center" rowspan="1" colspan="1">Molecules associated</th><th align="center" rowspan="1" colspan="1">Effect in tissue repair</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">Wound healing</td><td align="center" rowspan="1" colspan="1">hUCB-MSC</td><td align="center" rowspan="1" colspan="1">24&#x02009;hours</td><td align="center" rowspan="1" colspan="1">5 or 10&#x000a0;<italic>&#x003bc;</italic>M <italic>(in vitro)</italic></td><td align="center" rowspan="1" colspan="1">Increased mTOR<sup>ser2481</sup>, Akt<sup>ser407</sup>, PKC<italic>&#x003b6;</italic>, and MMPs</td><td align="center" rowspan="1" colspan="1">Increased cell migration and angiogenesis (10&#x000a0;<italic>&#x003bc;</italic>M)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B91" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Intestinal ischemic injury</td><td align="center" rowspan="1" colspan="1">Pigs</td><td align="center" rowspan="1" colspan="1">10&#x02009;days</td><td align="center" rowspan="1" colspan="1">0.5 or 5% of AA (diet)</td><td align="center" rowspan="1" colspan="1">Increased PGE<sub>2</sub></td><td align="center" rowspan="1" colspan="1">Preservation of epithelial barrier (5%)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B95" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">IBD</td><td align="center" rowspan="1" colspan="1">Rats</td><td align="center" rowspan="1" colspan="1">8&#x02009;weeks</td><td align="center" rowspan="1" colspan="1">0, 5, 35, or 240&#x02009;mg/Kg of bw (oral administration)</td><td align="center" rowspan="1" colspan="1">Increased COX-2, LTB<sub>4</sub>, TXB<sub>2</sub>, and MPO</td><td align="center" rowspan="1" colspan="1">Increased inflammation and macrophage infiltration</td><td align="center" rowspan="1" colspan="1">[<xref rid="B98" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Angiogenesis</td><td align="center" rowspan="1" colspan="1">Porcine endothelial cells</td><td align="center" rowspan="1" colspan="1">24&#x02009;hours</td><td align="center" rowspan="1" colspan="1">0, 20, 50, 60, and 80&#x000a0;<italic>&#x003bc;</italic>M <italic>(in vitro)</italic></td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Increased cell spreading (20&#x000a0;<italic>&#x003bc;</italic>M) and reduced cell spreading (80&#x000a0;<italic>&#x003bc;</italic>M)</td><td align="center" rowspan="1" colspan="1">[<xref rid="B101" ref-type="bibr">101</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Prostaglandin E2 (PGE<sub>2</sub>); inflammatory bowel disease (IBD); body weight (bw); cicloxigenase-2 (COX-2); leukotriene B<sub>4</sub> (LTB<sub>4</sub>); thromboxane (TXB<sub>2</sub>); myeloperoxidase (MPO); human umbilical cord blood-derived mesenchymal stem cell (hUCB-MSC); mammalian target of rapamycin complex 1 phosphorylation (mTOR<sup>ser2481</sup>); protein kinase B (Akt<sup>ser407</sup>); phosphorylates protein kinase C<italic>&#x003b6;</italic> (PKC<italic>&#x003b6;</italic>); matrix metalloproteinases (MMPs); not analysed (NA).</p></fn></table-wrap-foot></table-wrap></floats-group></article>